C O N G R E S SC H R O N I C L E S

61 IPSF WORLD CONGRESS 2015HYDERABAD INDIA 30th July to 9th August

ST Hosts

IndianPharmaceutical

Association

InternationalPharmaceutical

Students’ Federation

I am glad to know that the Indian Pharmaceutical Association - Students’ Forum (IPA-

SF), the student wing of the Indian Pharmaceutical Association (IPA) is hosting the

61st International Pharmaceutical Students’ Federation (IPSF) – World Congress 2015

at Hyderabad to be held from 31st July 2015 to 9th August 2015.

I am happy to note that for the first time ever that India is hosting such a historic World

event but also to make it a milestone event of the Indian Pharmaceuticals Association

(Students Forum) since its inception in 2008. The International pharmaceutical student

federation is the world’s largest professional Organization for budding pharmacists

covering 8 0 member countries amongst them Indian students forum has got best

students forum award in 2013 and then bid for Congress at Hyderabad. I would like to

congratulate the committee including IPA-SF which is a nearby 60 years old

organization and gathering of pharmacy professionals from all around the world.

I further wish that this occasion provides an opportunity for the best of young

professionals in this sector to deliberate and envision a greater commitment to the

future of Global Pharmaceutical Opportunities and also explore the Pharmacy

education as a holistic experience of learning with innovative pharma.

On this occasion, I wish the congress a grand success in experienced pharmacy with

innovative learning and I convey my best wishes to all.

Dr.P.V.AppajiDirector GeneralPharmaceu�cals Export Promo�on Council of India(Set up by Ministry of Commerce & Industry,Govt. of India)Hyderabad.

MESSAGE

I am extremely happy to learn that Indian Pharmaceu�cals Associa�on (IPA) has formed “IPA Students' Forum”, st

and are organizing "61 IPSF World Congress" at Hyderabad, which would be a great networking opportunity for students to interact and develop their technical skills and know-how of Pharma Industry. This pla�orm would be of mutual benefit to the industry in the search of future pharmacists with professional standards and students in search of good opportuni�es. Overseas Pharmacy students would also be benefi�ed by understanding more about India as a trusted source for supply of quality gene�c medicines at affordable prices . and India as Pharmacy of the World

Dr.P.V.AppajiDirector GeneralPharmaceu�cals Export Promo�on Council of India

Ms. Parand Akhavan

IPSF President, 2014-2015

Dear Par�cipant,

It is with great pleasure that I welcome you to the 61st IPSF World Congress. The IPSF Execu�ve Commi�ee is excited about the work IPSF and the Recep�on Commi�ee of Hyderabad, India, have done over the course of the past two years to organise this extraordinary event. In this booklet, you will find a detailed schedule and informa�on of all the scien�fic and educa�onal symposia, workshops, trainings, compe��ons andthe public health campaign. The abstracts of each event, backgrounds of each speaker, and the themes of each social event are here for your convenience. We invite you to engage through the rich experiences of dis�nguished speakers for our Scien�fic and Educa�onal Symposia and to par�cipate in our Public Health Campaign,different Professional Development Events and Poster Compe��on. Words alone cannot describe the spirit of IPSF, the hospitality of the Recep�on Commi�ee or the immense beauty and rich history of India. I hope that the informa�on provided here will be the guide to the memories you make and the experiences you will gain.Viva la Pharmacie!

Indeed it gives me immense pleasure to extend a warm welcome to the dis�nguished guests st thand delegates of the 61 IPSF world congress 2015, Hyderabad, India to be held from the 30

thJuly to 9 August 2015.

stThe onus of hos�ng this years annual grand event and for the 1 �me ever in India is rested upon the IPA-SF. It is an honor to organize such an event during my tenure of Chairperson. IPA-SF par�cipates in various ac�vi�es rela�ng to public health, pharmacy educa�on and student exchange. IPSF World Congress gives an addi�onal opportunity to the members of the associa�on to be part of such a big event. It is a pla�orm for all to learn the pharma world. The conference aims to focus on strategies for improving quality and feasibility of crea�ng a global competency frame work for pharmaceu�cal services, presence of high profile na�onal and interna�onal pharmacy professionals and young budding pharmacist with innova�ve minds which certainly make the IPSF WC an excellent pla�orm to discuss ways of moving pharmacy educa�on to a more ac�ve form.I am confident that the conference will provide a perfect venue for informa�on exchange and will provide an opportunity for networking among par�cipants. It will be an exchange of pharmaceu�cal culture. I also guarantee a comfortable and unforge�able experience to all of you in Hyderabad, the pearl city of India . I wish a successful delibera�on and look forward to the frui�ul outcomes of this event.

Mr. Rahul Lad

Presient, IPA-SF, 2014-15

Our Vision and Mission- IPSF-WC, 2015.

Warmest gree�ngs from the Recep�on Commi�ee of the 61st Interna�onal Pharmaceu�cal Students' Federa�on World Congress, 2015 (IPSF WC 2015). Having started this journey in July 2013, we have come a long way and it all circles back to why it started-the 61st IPSF WC 2015, India. The Indian Pharmaceu�cal Associa�on-Students’ Forum (IPA-SF) and I go a long way back. We first met in 2008-09 when I worked in the editorial commi�ee. During my progressive years at IPA-SF, I had the honor of being nominated as the editor and eventually elected as Chairperson of the Recep�on Commi�ee for this year’s World Congress. Blessed with a team of enthused commi�ee members and guidance from the Core members of the Indian Pharmaceu�cal Associa�on, we won the bid in 2013. And the most adventurous journey of my life began...

During the planning years, my team and I a�ended two World Congresses and one regional congress. Our fun-tas�c experiences at these events catalysed our planning to an enormous level. I believe that IPSF and all its Congresses are an amalgama�on of �meless friendships, undying unity and immense faith in it's principles that originate from building an innova�ve future for career aspirants in pharmacy across the world, regardless of their cultural or educa�onal background, and these con�nue to inspire us even to this day.

I had the good fortune of working with my remarkable Execu�ve Commi�ee and the Recep�on Commi�ee, a perfect combina�on of power with responsibility; a team that accomplished hours of me�culous planning and intense implementa�on. I strongly believe that team work is paramount to organizing this event of such magnificence. The Team of IPSF WC 2015 has proved it beyond belief.

A special men�on and big thank you to the Indian Pharmaceu�cal Associa�on (IPA) , the organiza�on without which we couldn’t have accomplished this herculean task.Their encouragement and unending support in all forms kept the ball rolling. Dr. T.V Narayana- our excellent mentor and Dr. Rao Vadlamudi- our dear IPA President (who were as strong headed as ever, yet role-played as our team members always) - seamlessly found a way out of any hurdle. Dr. T.B Nair- who at the age of 70 worked enthusias�cally and effortlessly, always showed us the posi�ve side to everything and paved our way through the past year! Mr. T. Jaypal Reddy, Dr. Surendra Manek, Mr. Kaushik Desai, Dr.Subodh Priolkar and Dr. Divakar Goli- our super able IPA Core team- pumped us up through thick and thin! It's because of all of them and my RC that every breakdown became a breakthrough- and we have come to realise our biggest crea�on- The 61st IPSF World Congress, 2015

It's now �me for us to create history that would go down a very long �me in the future. We are all set to flag off this grand event and we are as excited as you readers are, to be finally availing this Congress booklet to you. Every page of this booklet unfolds each day of the Congress to the minutest detail ensuring you have a wonderful �me at the Congress.

With this as my invita�on, I look forward to seeing all of you in the pearl-city, Hyderabad, India at IPSF-WC, 2015 where we

Un�l then, HAPPY READING!

To IPSF-WC,2015…IPSF-WC,2015…VIVA LA PHARMACIE!

Neha Dembla Chairperson, 61 IPSF World Congress, India st

Chairperson , IPSF-WC,2015 , Recep�on Commi�ee- Message

Gree�ngs from the Indian Pharmaceu�cal Associa�on (IPA)! It is indeed a ma�er of immense pleasure and great pride for me and the IPA to realise that our student body, the IPA -Students' Forum (IPA -SF), in a short period of 8 years since incep�on has made giant

strides, firstly by bagging the pres�gious Sidney J. Ralph award of the Interna�onal Pharmaceu�cal Students' Federa�on (IPSF) for being the best student forum and secondly by taking the bold step to organise the 61st IPSF World Congress 2015 in India in Hyderabad in July-Aug 2015. The IPSF World Congress, the biggest event of the IPSF is organized by each member associa�on every year. The World Congress is a 10 -day event, which serves as a great opportunity for students from 85 countries to "Connect-Catalyse-Innovate" to usher a bright future for both pharmacy prac�ce and pharmacy educa�on locally and globally. For IPA it is a proud moment to support the IPA - SF recep�on commi�ee and to witness them organising the 61st IPSF World Congress 2015 successfully. I feel extremely privileged to be a part of the "The 61st IPSF WC 2015" and wish the World Congress huge success!!

Messages

Rao V. S. V. Vadlamudi, Ph. D., President, Indian Pharmaceu�cal Associa�on (IPA)

E-Mail: rao.vadlamudi@gmail.comraovsvv@ipapharma.org,

Rao V. S. V. Vadlamudi, Ph. D. Hyderabad. July 1, 2015

THE INDIAN PHARMACEUTICAL ASSOCIATION (EDUCATION DIVISION)

Office at: S.B.D.College of Pharmacy. I Cross, Hanumanthanagar, Bangalore -19. Email:tvnarayana2000@yahoo.com

Dr. T.V.Narayana

Message

Dr. T.V.Narayana

Vice-President – IPA and

Chairman, IPA-Education Division

It gives me an immense pleasure to know that the 61st IPSF world congress is being organized by IPA-

Students Forum and IPSF at Hyderabad, Hotel Marriot Convec�on Centre from 30th July to 9th of August

2015.

Pharmacy educa�on is key element to the changing �des of the young pharmacy work force. There have

been considerable efforts expended in India to keep up the unprecedental changes in pharma educa�on as

a whole. IPA educa�on division as a mentor of IPASF is con�nuously striving and guiding the pharmacy

students to play a major role in the field of pharmacy.

I wish the 2day scien�fic and educa�on symposium during the congress will give an insight to both aspiring

and young professionals and will provide an excellent opportunity to the delegates to exchange view as on

emerging tread on pharmacy educa�on and science.

I appreciate the efforts and hard work of the students in releasing the congress chronicle and extend my

hear�est gree�ngs and wishes to the organizers.

Hyderabad, the city of rich cultural heritage is the venue of 61st International Pharmaceutical Students’ Federation – World Congress 2015 organized by Students’ Forum, the Student Chapter of Indian Pharmaceutical Association (IPA). The theme encompassing “API to Formulation – Process, Quality and Economics” is aptly cho sen considering the position India enjoys globally as a manufacturing hub. On behalf of IPA, I warmly welcome all the participants who have travelled from all over the globe. The credit of putting together an excellent program goes to the committed student members ably supported by IPA leadership team and mentored by Education Division of IPA. I wish you all a pleasant stay and an enjoyable and enriching experience with constructive exchange of ideas through meaningful interactions and scientific deliberations.

M E S S A G E

Kaushik Desai

Hon. Gen. Secretary

Dear Future Pharmacists and Pharmaceutical Scientists,

I would like to commend you for taking part in the biggest annual gathering of Pharmaceutical students in the world. The theme of this congress, “Encompassing API to Formulation — Process, Quality & Economics”, highlights the valuable knowledge that pharmacists and pharmaceutical Scientists bring to the discovery and development of medicines. The International Pharmaceutical Federation (FIP) believes that molecules become medicines only through the addition of pharmaceutical expertise. As future pharmacists, your mission will be to optimise the effects of these medicines through ensuring responsible use. Remember always, that patients are our priority and that medicine is a tool to achieve well-being. By being in Hyderabad, you are demonstrating four key qualities. The first is a wish to Connect with others, exchange ideas and tackle challenges together. The second is an Eagerness to learn, not only about pharmacy but about different cultures. The third is a Passion for pharmacy and, moreover, for the future of our profession. The final quality is an interest in international pharmacy. This is an excellent interest to have during your studies or early in your careers; globalisation in healthcare is growing in Significance. FIP is recognised as the leader of pharmacy at a global level. I hope your Interest continues as your careers progress and that you later become part of FIP. May the discussions you have at this 10-day IPSF event lead to many future achievements.

Dr Carmen Peña President

International Pharmaceutical Federation (FIP)

Association of Pharmaceutical Teachers of India No.620 D, 35th Cross, 2nd Block, Rajajinagar,

Bengaluru-560 010, INDIA 080 – 23325094

http://www.aptiindia.org

“Committed for Quality Pharmacy Education”

MESSAGE 1/7/2015

Dr. Mahesh D. Burande President mahesh.burande@gmail.com Mobile: +919822016759

APTI is very much delighted to know that Indian Pharmaceutical Association through its IPA Students’ Forum is organizing first time in India IPSF World Congress 2015 at Hyderabad India. APTI welcome Pharmacy Students from 60 countries to India. Pharmacy Profession is a novel profession to serve the humanity. Super mighty has given us this golden opportunity to contribute as Pharmacist to save life, nurture life ,protect life and extend life by working as Pharmacist in different segments of Pharma cy Profession .To become successful in Pharmacy Profession love your profession, be passionate about your profession, think Positive and do tremendous hard work with discipline. You give the Pharmacy World best you have and best will come back to you. Let’s work together to bring solutions to make world happy and healthy and provide the best health care service so that society can remember the Pharmacist and Pharmacy Profession as No.1 profession . Finally God gave us two gifts; one is choice and second is chance------the choice of a good life and chance to make it the best life. If you came to Pharmacy Profession as your first choice, serving this profession your life will be very good. Even if you came to this profession by chance you can still make your life the best one by serving the people and making them happy. All the best for your life time careers in Pharmacy Profession.

Dear Students,

stI congratulate you on hosting 61 Interna�onal Pharmaceu�cal Students' Federa�on (IPSF) – World Congress 2015 in Hyderabad, India star�ng from July 31, 2015.It gives me great pride and sa�sfac�on as IPA member that in such short �me, you have accomplished a might task. Personally, it had added dimension of achievement as I was the one who ini�ated IPA SF ac�vity in Maharashtra State as President of IPA- MSB. The objec�ve was to involve students in professional ac�vi�es at early age to create a young genera�on of Members for IPA and to create a sense of belonging in students towards IPA.

As President of IPA, I was involved in planning IPA SF at na�onal level and my successor, Dr. Suresh formalised it into sub division of Educa�on division of IPA. It is heartening to see it blossoming it to global level.I have seen hard work done by team to get this event to India and have full confidence in the team that the event will be a great success.

All the best and keep India flag flying high,

Regards,

Subodh PriolkarM.D. Colorcon

Message

It gives me extreme pleasure to know that the st61 International Pharmaceutical Students' Federation World

Congress (IPSF - WC) 2015 is being organised by Indian Pharmaceutical Association - Students Forum (IPA-SF) th th

from 30 July to 8 August 2015 at Marriott Convention Centre, Hyderabad with the Theme Encompassing API to

Formulation-Process, Quality & Economics.

The delegates participating in the congress will share their rich experience and expertise on issues relating to

the theme and global research in the field of the Pharmacy. The congress will surely be a platform and will provide

an opportunity for the budding pharmacists to express themselves towards research and development.

I hope the deliberations on the theme of the conference will find out solutions for ensuring quality pharmacy

education and research in global level.

I congratulate Local Organizing Committee of IPASF-WC 2015 and extend my best wishes, warm greetings

and felicitations to the participants for the grand success of the World Congress.

Sd/. President Indian Association of Colleges of Pharmacy

stIt is ma�er of immense pride that 1 IPSF World Congress is being organized by IPA Students' Forum

th that Marriot Convec�on Centre on 30 July to 9 of August.I wish the delivera�ons of Scien�fic and Technical sec�ons during the congress would offer healthy pla�orm to the students to apprise themselves with latest technological advancements in the field of Pharmacy.On Behalf of AIDCOC I congorulate IPA- Students' Forum for organizing such a mega event for the first �me in India. I extend my best wishes to the congress.

Ravi Uday BhaskarSecretary General AIDCOC

Venue and Accommoda�on: The main venue for the event is Marrio� Hotel and Conven�on Centre. Par�cipants will be

accommodated in Marrio� hotel. Rooms will be allo�ed to the delegates on arrival. Room Deposit

of €50/delegate will be collected by hotel staff.

Address: Hyderabad Marrio� Hotel and Conven�on Centre,

Opposite Hussain Sagar Lake, Tank Bund Road, Hyderabad – 500080

rd thAll the meals except (lunch on 3 August and dinner on 5 August would be served at a separate venue)

will be served at Marrio� Hotel. No lunch will be provided on July 30, 2015. No dinner will berdprovided during the free night on 3 August.

General �mings (please refer to the app for specific changes in meal �mings):

Breakfast: 6:30 am to 8:30 amst 1 Tea Break

Lunch: 12:30 pm to 1:30 pmnd 2 Tea Break

Dinner: 7:00 pm to 8:30 pm

INFORMATION DESKS:

A 24 hrs informa�on desk will be placed outside the conven�on area of Marrio� hotel. Our volunteer

will always be there to answer your ques�ons round the clock. However feel free to contact any

m e m b e r o f t h e te a m . C o nta c t d eta i l s a re p rov i d e d i n t h e fo l l ow i n g s e c � o n s .

Smoking and An� - Drug policy:

IPSF has a strict an� - drug policy which will be no different in this Congress. People who wish tondsmoke can walk down to the smokers zone (lobby level and 2 Floor). Alcohol consump�on is strictly

prohibited for the ages below 21. Anyone found with any drugs would be handed over to the police

by the Marrio� personnel and neither IPA-SF, IPSF nor Marrio� would be responsible for the release

of the student.

Other informa�on/ Key notes:

¡ An amount of €50 should be deposited upon check-in into the hotel which will be

refunded a�er check out. (Provided the list of items as men�oned in the room deposit

policy remain undamaged at the �me of check out).

¡ An iden�ty card should be worn during every event �ll the end of the Congress for

iden�fica�on purpose. Without the iden�ty card delegate will not be allowed to a�end any

session/ party. If the card is lost a fine of €5 will be charged.

ARE YOU HUNGRY?

¡ Registra�on for the workshops should be done through the online forms which will be

shared by the RC.

¡ Transporta�on for all the official events throughout the Congress will be provided by

the RC.

¡ Please maintain decorum and follow schedule �mings as guided by the RC and Ex-Co

since together we will be responsible for the smooth running of the event.

¡ Any changes in the schedule will be brought to your no�ce at the informa�on desk

and also will be communicated through the app and daily newsle�ers – so stay

updated at all �mes!

Congress a�endance system : The recep�on commi�ee and IPSF have designed an a�endance system in which

a�endance will be measured by the stamp cards which will be distributed at the

beginning of the Congress and has to be kept safe when lost a fine of 5 € should be paid

to get a new card.In order to receive the 61 IPSF world Congress cer�ficate the st

a�endance criteria is as follows:

¢ 100% of all educa�onal and scien�fic symposia sessions.

¢ 50% of the other workshops and events.

¢ This should collec�ve make a minimum of 75% of total a�endance.

¢ The par�cipants coming for the first �me should a�end the “discover IPSF” session.

Emergencies:

¢ A doctor will be available throughout the Congress for an medical assistance

¢ The general emergency phone number for police in India is 100.

¢ In case any emergency alarm is heard please stay calm and listen to the orders of RC or

the professional emergency services.

English Hindi TeluguHello Namaste NamasteThank You Dhanyawad DhanyawadaluPlease Kripaya DayachesiI`m sorry kshaminchandimaaf kijiye

My Name is mera naam na peruHow are you kaise ho? ela unaru?what is your name aap ka naam kya hai mi peru aentiwhere are you going? kaha jaa rahe ho? ekada potunaruYou aap meruwe hum memuThey voh vaaluYes haan avunuNo nahi kadhuWhat is that? voh kya hai? ade aenti?How much does it cost? kitne ka hai? ade aennta?What time is it? time kya hua hai? time aenta?where is it? kaha hai? aekada undi?free muffth uchitamuOpen khula tersiClose band musasiRight

daaya

kudiLeft

baayayedama

I don’t understand a bit! mujhe kuch samajh nai aaraha! Naku ardam avatledhu!I understand just a bit! mujhe thoda samaj raha hai naku koncham ardam ayetundiyou speak too fast! aap bahuth tez baat kar rahe ho miru chala twaraga matladtunarua bit thoda konchamI don’t know, I can only speak english! mujha samaj nahi aaraha! naku ardam avatla, I understand english only!

Desi Transla�ons

0 July 30 2015

All day Arrivals, check-in, welcome party

Day 0

July 31 2015

7:00 - 9:00 About IPSF CP meeting SEO meeting

9:00 - 12:00

13:00 - 15:00

15:30 - 17:00Model United Nations:

IntroductionIPSF Pharmacy Profession

Awareness CampaignPublic Health: Communicating in

the Digital AgeDr. H.D.R Vincent Jannin

Dr. Nabil Joseph Farah

Opening Ceremony

IPSF in your corner FIP + YPG

GA

Day 1

August 2 2015

9:00 - 9:45 Mr. Subodh Priolkar

9:45 - 10:30 Dr. Purnanand Sarma

10:50 - 11:35 Dr. Krishna Ella

11:35 - 12:20 Dr. Madhu Pudipeddi

13:40 - 14:25 Dr. Akash Mathur

14:25 - 15:10 Mr. Anirudh Gautam

15:30 - 16:15 Mr. Manni Kantipudi

16:15 - 17:00 Dr. Mahesh Bhalgat

Can India Sustain its Position as a Global Generics Provider

Innovation & Vaccine Hub of the World

Innovation and Entrepreneurship together Paving way for New Therapies with Better Outcomes

Day 3

Scientific Symposium "Catalyzing Innovation in Manufacturing and Delivery of Pharmaceutical Products"

Key-note address

Business Potential of Innovative Pharmaceutical Services vis a vis Pharmaceutical Products

Role of Innovation in Generic Product Development

Leveraging Innovation to offer Cutting Edge Pharmaceutical Research Solutions to Global Industry

Opportunities and Challenges in Biotechnology-based products and the Role India can Play

August 3 2015 Day 4Excursion

RAs

August 4 2015

9:00 - 10:30IPSF Clinical Skills Event -

Introductory WorkshopSaree Draping-Exclusively

for GirlsAttitude to Altitude in Pharmacy

Profession Increasing the

Employability Quotient

11:00 - 12:30IPSF Patient Counseling Event -

Introductory WorkshopTurban Draping- Preferably

for BoysAttitude to Altitude in Pharmacy

Prrofession Effective Documentation

13:30 - 15:00IPSF Compounding Event -

Introductory WorkshopEPSA-IPSF Workshop

Continous Manufacturing, “Granulation”: An overview

Student Exchange Officer- Workshop

15:30 - 17:00Pharmacy at Your Fingertips –

Using Technology to Strengthen Your Therapy Decisions

IPSF 7 Minutes to Inspire AMR: Clinical Skills &

Awareness"Pharmaceutical R&D: New

frontiers of innovation"

Day 5

GA

August 5 20159:00 - 10:3011:00 - 12:3013:30 - 15:0015:30 - 17:00

Industrial visit

PHC PreparationsGA

Day 6

Daily Schedule

August 1 2015

9:00 - 9:45 Dr. B. Suresh

9:45 - 10:30 Dr. Chandra Shekar

10:50 - 11:35 Prof. C. K. Kokate

11:35 - 12:20 Dr. Srinivas Pentyala

13:40 - 14:25 Prof. Ralph J Altiere

14:25 - 15:10 Mr.T. K Ravi

15:30 - 16:15 Mr.T. JayaPal Reddy

16:15 - 17:00 Dr. T. V. Narayana

Day 2

Educational Symposium "Bridging Gaps in Current Pharmacy Education"

Role Model in Science: Teacher, Advisor, Mentor and a Friend

Pharmacy Education: Uniformity in course content

Entrusting Students to be Agents of Change

Advanced learning and practice - Creating global standards

QA of pharmacy education. Role of stake holders.

Empowering the Future Enterpreneur to global leadership

Pharmacy Education - Renaissance

US pharmacist in 2015 – highly trained professionals, fighting for recognition as health care provider, one state at a time

August 7 2015

9:00 - 10:30 Gattefosse

The National Health Service in the UK: The

Cost of Care and Future of Hospital Pharmacy

TRIPS and Post 2015: Opportunities to improve access

to medicine

Conflict Resolution in Workplace relationships

11:00 - 12:30Role of IPC in defining and

maintaining quality standards of Medicines

Root Cause Analysis and CAPA system

Improving Patient Compliance by Formulation Design

Packaging Validation: A critical need to ensure valid

product

13:30 - 15:00IPSF Clinical Skills Event -

Individual AdvancedModel UNESCO

IPSF Clinical Skills Event - Individual Beginners

Pharmacovigilence: An eye for detail in ADR

Management

15:30 - 17:00Pharmacy Education Summit:

Being the Ambassador for Change!

Model WHO IPSF Training OpportunitiesQuality Risk Management

in Pharma Industry

GA

Compounding event (from

13:00)

Day 8

August 8 2015

9:00 - 10:30Good practices in

pharmaceutical industryPharmacokinetics and its

applicationsIPSF Patient Counselling Event -

FinalsHow to Run an Innovative

Public Health

11:00 - 12:30Engaging Pharmacy Students in

Public Health Activities

Career opportunities in Regulatory Affairs utilizing knowledge of Regulatory

Sciences

IPSF Clinical Skills Event- Jeopardy

How to Run an Innovative Public Health

13:30 - 15:00Mrs. Archana Mugdhal workshop

- Waiting for confirmationChallenges of Membership

Promotion

Herbal formulation industry in India: Challenges and

opportunities

GMP - Recent Trends and developments

15:30 - 17:00Pharma Research: Industry-

Academia-Regulatory Concern, case Studies

Research Methodologies Pediatric Pharmacy Strategies for writing

research paper

Day 9

GA

August 6 2015

9:00 - 10:30Public Health:

Communicating in the Digital Age

Project Management -

11:00 - 12:30 IPSF Clinical Skills Event -

Case Presentation Competition

Present needs of the Indian Pharma Industry from

Academia -

13:30 - 15:00

The 3rd IPSF Young Researchers’ Forum I - World Café Discussion on Pharmacy

Students Involvement in Research Projects

RC Workshop - Reserved

15:30 - 17:00

The Great New Challenges facing the Pharmacists Worldwide in the New

Millennium

-

IPSF Clinical Skills Event - Team Competition

IPSF Patient Counselling Event - Beginner Preliminaries

IPSF Patient Counselling Event - Advanced

Preliminaries

PHC Group 1

PHC Group 2

Day 7

ARRIVALS AND CHECK – INAll the participants are requested to sign up at the registration desk upon arrival. Room keys and Kitbags will be provided to every delegate after financial and registration clearance at the desk. You will be guided at every step along the way.

WELCOME PARTYThe Reception Committee will warmly welcome the delegates and IPSF Ex-co at this party. The party will include Flag- Ceremony where each IPSF Full Member will get the flag of the country they are representing. The party will also have a lot of icebreakers, lightening the environment and making it conducive for interactions for IPSFers participating at 61st IPSF World Congress.

Day 0

Day 1

ABOUT IPSFVenue: Amber HallSpeaker: IPSF Execu�ve Commi�eeThis workshop will introduce newbies to the IPSF Universe and enhance the knowledge of experienced members. Join the workshop and get energized for the upcoming days.

CP MEETINGVenue: Topaz HallSpeaker: IPSF Execu�ve Commi�eeContact Persons from all associa�ons meet to discuss the past year and needs for the future.

SEO MEETINGVenue: Opal HallSpeaker: IPSF Execu�ve Commi�eeStudent Exchange Officers (SEO) from all associa�ons gathers to discuss the past year and needs for the future.

OPENING CEREMONYVenue: Marrio� Conven�on CentreThe opening ceremony would be a formal ceremony on the first morning of the World Congress which would be inaugurated by Sri. K. T. Rama Rao, the Honarable Minister of Raj Panchayat and Informa�on Technology, Government of Telangana.DRESS CODE: pick the most formal ou�it from your wardrobe.(SHOULD BE BELOW KNEE LENGTH, AS GOVERNMENT PEOPLE ARE EXPECTED AT THE OCCATION )

0 July 30 2015

All day Arrivals, check-in, welcome party

Day 0

July 31 2015

7:00 - 9:00 About IPSF CP meeting SEO meeting

9:00 - 12:00

13:00 - 15:00

15:30 - 17:00Model United Nations:

IntroductionIPSF Pharmacy Profession

Awareness CampaignPublic Health: Communicating in

the Digital AgeDr. H.D.R Vincent Jannin

Dr. Nabil Joseph Farah

Opening Ceremony

IPSF in your corner FIP + YPG

GA

Day 1

IPSF IN YOUR CORNERVenue: Pearl Garden, Halls – Topaz, Opal, AmberSome Fun�me in groups at various corner of the venue.FIP + YPGVenue: Emrald HallFor young budding pharmacists to be introduced into the pharma world on a pla�orm like IPSF WC

MODEL UNITED NATIONS: INTRODUCTIONVenue: Topaz HallSpeaker: Ms. Barbara Villela, IPSF Chairperson of Public Health MANCE POWERED BY MICRO NANO SYSTEMS USING S. E. L. F. Venue: Turquis Hall

IPSF PHARMACY PROFESSION AWARENESS CAMPAIGNVenue: Amber HallSpeaker: Ms. Stephenie Miler, IPSF Chaireprson of Professional DevelopmentLearn how to promote your profession and create a difference in the healthcare industry.

PUBLIC HEALTH: COMMUNICATING IN THE DIGITAL AGEVenue: Diamond HallSpeaker: Mrs. Nirma Khatri Vadlamudi"According to an Ins�tute of Medicine (2004) report, low health literacy nega�vely affects the treatment outcome and safety of care delivery. Several studies reveal that up to half of pa�ents cannot understand basic healthcare informa�on. The mismatch between a clinician's level of communica�on and a pa�ent's ability to understand can lead to medica�on errors and adverse medical outcomes. The lack of health literacy affects all segments of the popula�on, although it is dispropor�onate in certain demographic groups, such as the elderly, ethnic minori�es, recent immigrants and persons with low general literacy. Pharmacist plays a key role in bridging the gap of lack of health literacy skills among pa�ents and improper communica�on with clinicians through health communica�on.In this Public Health Communica�on workshop, the instructor takes the par�cipants through various behavior change theories, health message framing strategies, communica�on styles to effec�vely develop public health message for Direct Pa�ent Care, Counseling or Public Health campaigns. Par�cipants will get hands-on experience by working on real case studies".

WORKSHOP BY GATTEFOSSEVenue: Coral hallSpeaker: Dr. H. D. R. Vincent Jannin

PHARAMCEUTICAL PERFORPERFORMANCE POWERED BY MICRO NANO SYSTEMS USING S. E. L. F. Venue: Turquoise Hall

August 1 2015

9:00 - 9:45 Dr. B. Suresh

9:45 - 10:30 Dr. Chandra Shekar

10:50 - 11:35 Prof. C. K. Kokate

11:35 - 12:20 Dr. Srinivas Pentyala

13:40 - 14:25 Prof. Ralph J Altiere

14:25 - 15:10 Mr.T. K Ravi

15:30 - 16:15 Mr.T. JayaPal Reddy

16:15 - 17:00 Dr. T. V. Narayana

Day 2

Educational Symposium "Bridging Gaps in Current Pharmacy Education"

Role Model in Science: Teacher, Advisor, Mentor and a Friend

Pharmacy Education: Uniformity in course content

Entrusting Students to be Agents of Change

Advanced learning and practice - Creating global standards

QA of pharmacy education. Role of stake holders.

Empowering the Future Enterpreneur to global leadership

Pharmacy Education - Renaissance

US pharmacist in 2015 – highly trained professionals, fighting for recognition as health care provider, one state at a time

Pharmacy Educa�on – Renaissance

Dr. B.Suresh, Vice-Chancellor, JSS University, Mysore & of Pharmacy Council of India, New Delhi

Prof Bhojraj Suresh, M.Pharm., Ph.D., Vice-Chancellor, JSS University, for the past thirty years has been ac�vely involved in upli�ing the standards of pharmacy educa�on and profession in

India. He was elected in 2003 as the President of Pharmacy Council of India, the statutory body regula�ng the pharmacy educa�on and profession in India. He was once again re-elected as the President of Pharmacy Council of India in August 2008 and August 2013 and has the unique honor being elected thrice to this leadership posi�on. He is also the Chairman of the Scien�fic Body of Indian Pharmacopoeia Commission, which is responsible for se�ng of standards for pharmaceu�cal substances and formula�ons.

Dr. Suresh is also the delegate member of the United States Pharmacopeia Conven�on and also the member of the Council of Conven�on of the USP. He has been invited to be the member of ACPE Interna�onal Services Program Advisory Group, USA and is the Execu�ve Member of CPA. He was also the past President of Asian Associa�on of Schools of Pharmacy and Chairman of the Educa�on Sec�on of the Federa�on of Asian Pharmaceu�cal Associa�on.

He had pioneered the cause of promo�ng “Pharmacy Prac�ce” concept in India and has the unique honour of having introduced postgraduate programme in “Pharmacy Prac�ce” and “Pharm D” programmes in India and con�nues to strive to upli� this facet of pharmacy profession by closely working with other global leaders.

Dr Suresh has to his credit several na�onal and Interna�onal publica�ons and has ini�ated several interna�onal collabora�ons through bilateral, academic and research exchange programmes. He has to his credit of having organized several na�onal and interna�onal mee�ngs and conferences in India and elsewhere, and had spearheaded the organizing of the World Congress of Pharmaceu�cal Sciences 2011, 71st Interna�onal Congress of FIP.

He has ac�vely involved himself with the educa�on ini�a�ves of FIP and been an ac�ve member of FIP Pharmacy Educa�on Task Force. In recogni�on of his invaluable services in the field of pharmaceu�cal educa�on, he is a recipient of several na�onal and interna�onal awards.

In recogni�on of his invaluable services in the field of pharmaceu�cal educa�on, he is a recipient of several na�onal and interna�onal awards and to men�on in par�cular the FAPA Ishidate Award–2004 (Interna�onal Award) and Doctor of Science (D.Sc.,) Honoris Causa conferred by The Tamilnadu Dr MGR Medical University, Chennai in 2007 and by the Rani Durgavathi Vishwavidyalaya , Jabalpur, Madhya Pradesh in 2012.

Day 2 Schedule (August 1)

Dr B.Suresh is also the recipient of the presi�gious ' Eminent Pharmacist Award' of the Indian Pharmaceu�cal associa�on , the 'ML Shroff award' of the Indian Hospital Pharmacists Associa�on and the 'KC Cha�erjee award' of the Indian Pharmacy Graduates Associa�on. Dr.B Suresh is also the 'Interna�onal Commissioner' of Accredita�on council for Pharmacy Educa�on, (ACPE) USA.

He con�nues to provide his leadership role in his mul�faceted career by serving on several na�onal and Interna�onal statutory commi�ees, viz. Drug Technical Advisory Board, Na�onal Board of Accredita�on, na�onal commi�ee for Clinical establishments and commi�ee for Control and Supervision of Experiments on Animals (CPSEA).

He is fondly liked by all his colleagues for his humane approach and his excellent team leadership.

Abstract:Pharmacy educa�on in India has undergone a paradigm shi� in the last two decades. More than 1500 Pharmacy ins�tu�ons in India cater to the varying needs of the profession at different levels. Un�l li�le more than a decade the pharmacy graduates were involved mostly in manufacturing of medicines and the tradi�onal dispensing of medicines and pa�ent care services were supported though pharmacists who had a two year diploma in pharmacy qualifica�on. Although, this resulted in tremendous growth and innova�on in Pharma Industry leading to India as a global Pharma des�na�on, it failed to gain societal recogni�on for the pharmacy profession. The concept of pa�ent-oriented pharmacy prac�ce was first introduced in India in the year1995, by the introduc�on of prac�ce-based and pa�ent-focused postgraduate course, Master of Pharmacy in Pharmacy Prac�ce. However, a Renaissance in Pharmacy educa�on took place only a�er the introduc�on of the prac�ce-based, six years, 'Doctor of Pharmacy (PharmD)' degree course by the Pharmacy Council of India in the year 2008. This mul�-faceted course has redefined the role of pharmacists in the Indian healthcare system. There has been a paradigm shi� resul�ng in the (i) increased number of students-pharmacists working in the wards of hundreds of hospitals and (ii) increased pharmacists' capabili�es in providing pa�ent care services. The future of the pharmacy profession lies on (i) developing well-qualified, knowledgeable, skilled and competent human resources (ii) providing high quality pharmaceu�cal care services in healthcare system and (i i i) fulfill ing the other professional obliga�on/responsibili�es based on the societal need. These could only be achieved through change in the legisla�ve framework in order to improve and maintain high standards of pharmacy profession both educa�onal as well as prac�ce se�ngs.

US pharmacist in 2015 – highly trained professionals, figh�ng for recogni�on as health care provider, one state at a �me.

Dr. M. Chandra Sekar

M. Chandra Sekar did his B.Pharmacy (1974), M. Pharmacy (1976), Birla Ins�tute of Technology and Science, Pilani, India. His M. S. (1980), Ph.D. in Molecular Pharmacology (1984), University of Bri�sh Columbia, Vancouver, Canada and Post Doctoral training (1984 - 1987), University of Wisconsin, Madison, U.S.A.

M. Chandra Sekar was working as professor of Pharmaceu�cal Sciences from 2013, University of Findlay, Findlay, Ohio. He worked as the Associate Professor Pharmaceu�cal Sciences (2007 – 2013) in University of Findlay, Findlay, Ohio and Adjunct Professor (2010 – Present) in JSS University, Mysore, India and Pharmacist- PRN (2007 - 2010) in University of Cincinna� Hospital, Cincinna�, Ohio and Pharmacist (2000 – 2007) in University of Cincinna� Hospital, Cincinna�, Ohio and Pharmacist (1999 – 2000) in Bay Medical Center, Panama City, Florida, Research Assistant Professor (1988 -1999), School of Medicine, Departments of Pathology and Pharmacology in University of Alabama at Birmingham, Birmingham, Alabama and Associate Scien�st (1991 - 1999) in Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.

He was the Invited speaker CIMS-CON 2012, Associate Editor, Journal of Pharmaceu�cal Sciences and Pharmacology (2013 to present) and a�ained many other awards and recogni�ons.

He has membership in organisa�ons like American Associa�on for Advancement of Science,American Society of Biochemistry and Molecular Biology,American Society of Pharmacology and Experimental Therapeu�cs,American Pharmacist Associa�on,Ohio Pharmacist Associa�on, ASIOA – life member.

He was licenced in Ohio Pharmacist License – 07/00 and Florida Pharmacist License - 03/95 – 10/12.

Abstract

While the word “pharmacist” is used for pharmacy--educated professionals in many parts of the world, scope and expecta�ons for what that professional is capable of doing varies widely. Few decades ago, even in US, pharmacist's responsibility only extended into filling doctor's prescrip�on accurately. At that �me, few mo�vated students who went onto get addi�onal training, were awarded Pharm D – and those graduates primarily staffed clinical posi�ons at large hospitals or pursued research and teaching at universi�es. Since 2002, US have shi�ed to Pharm D degree as the basic requirement for entry into pharmacy profession. This has resulted in longer and more expensive training for students. While educa�onal qualifica�ons and training for gradua�ng pharmacists has expanded drama�cally over the last decade in US, the actual progress in professional prac�ce experience have been more limited. Introduc�on of “affordable care act” has s�mulated the need for greater collabora�on between various healthcare professionals to improve pa�ent outcome. Some recent victories in recogni�on of pharmacists as providers on selected reimbursement programs – is a good beginning; though we s�ll have a long way to go. While clinical pharmacists and their services will be useful in almost every corner of the world, usefulness of any moderniza�on and update of pharmacy curriculum could only be realized if they are simultaneously accompanied by cri�cal updates on rules and regula�ons governing the pharmacy profession and appropriate reimbursement mechanisms for pharmacist services.

Pharmacy Educa�on: Uniformity in course contentProf. (Dr.) Chandrakant Kokate, Vice-Chancellor, KLE UNIVERSITY, BELAGAUM. Karnataka, INDIA.

Prof. (Dr.) Chandrakant Kokate is the Present Pharmacy Board Chairman of NAAC. He was the Vice–Chancellor, Kaka�ya University, Warangal, A.P. He was President, 50th Indian Pharmaceu�cal Congress along with Federa�on of Asian Pharmaceu�cal Associa�on (FAPA), Na�onal President-Indian Pharmaceu�cal Associa�on, President-Indian Society of Pharmacognosy.

Prof.C.K.Kokate is Chairman-Expert Panel Commi�ee for approval of Fixed Dose Combina�ons,(FDC's) Ministry of Health, Government of India. Chairman, Pharmacy Accredita�on Commi�ee of Na�onal Board of Accredita�on (NBA).His NATIONAL & INTERNATIONAL AWARDS AND FELLOWSHIPS including Eminent Pharmacist Award of Indian Pharmaceu�cal Associa�on, Prof.G.P.Shrivasta Award of Associa�on of Pharmaceu�cal Teachers of India, Prof.M.L.Schroff Award of Indian Hospital Pharmacists Associa�on, Prof.M.L.Khorana Award of Indian Pharmaceu�cal Associa�on, Shri.K.C.Cha�erjee Award of Indian Pharmacy Graduates Associa�on, Shri.B.V.Patel Award of B.V.Patel Trust; and Life Time Achievement Awards of Associa�on of Pharmaceu�cal Teachers of India; Indian Society of Pharmacognosy; Indian Associa�on of Pharmaceu�cal Scien�sts & Technologists and Interna�onal Society of Ethnopharmacology (Indian Chapter).He guided 17 students for Ph.D programme and 40 students for PG in Pharmacy. He authored seven books in Pharmacognosy / Pharmacy. One book is in 50th Edi�on. Around three lakhs copies have been sold, so far. He Published about 115 research papers in Na�onal and Interna�onal Journals. He Examined so far, 70 Ph.D. theses in Facul�es of Medicine, Pharmacy, Science and Technology. He chaired 20 Scien�fic sessions at Interna�onal Conferences and around 50 Na�onal Mee�ngs.He presented 50 research papers at Interna�onal Conferences and about 120 papers at Na�onal Mee�ngs.

Abstract

The landscape of pharmacy educa�on across the globe has witnessed significant qualita�ve and Quan�ta�ve transforma�on since the beginning of 21st Century. Over past two decades, India has covered a long distance on the path of expanding the ins�tu�onal infrastructure for dissemina�ng educa�on in pharmaceu�cal sciences. The accredited pharmacy ins�tu�ons in different parts of the world are expected to be the epicenters of knowledge explosion by ac�ng as nuclei for knowledge crea�on, storage and dissemina�on. In order to understand global trends in pharmaceu�caI sciences, some degree of uniformity is expected in the course content of pharmacy, keeping in view the emerging areas of pharmacy prac�ce and pharmaceu�cal Technology. The accredited pharmacy ins�tu�ons in different parts of the world are expected to be the epicenters of knowledge explosion by ac�ng as nuclei for knowledge crea�on, storage and dissemina�on. In order to understand global trends in pharmaceu�caI sciences, some degree of uniformity is expected in the

In this presenta�on, I will cover the major components of the current curriculum in US, how they are delivered and student's expecta�ons and outcomes. Presenta�on will also focus on major factors – both societal and healthcare related that is responsible for underu�liza�on of pharmacist exper�se in US, and what prepara�ons and groundwork need to be done before rolling out Pharm D program in developing countries that really has an impact on the public health outcome for that country.

course content of pharmacy, keeping in view the emerging areas of pharmacy prac�ce and pharmaceu�cal Technology.

In the context of globaliza�on of professional educa�on, it is expected that a pharmacy student migra�ng from one country to the other is able to adopt to the changed ecosystem of educa�on dissemina�on with comfortable degree of sa�sfac�on.The need of the hour is ensure some degree of uniformity in academic program offered at the graduate level in pharmacy. At least, 75 percent of the course content in pharmaceu�cal sciences should be uniformly covered, while remaining 25 percent could vary based on the local requirements and expecta�ons. The advancements in the fields of drug development, manufacturing pharmacy, quality control and quality assurance, pharmaceu�cal biotechnology and pharmacy prac�ce are required to be understood by all the students of pharmacy across the globe.

The curriculum of professional courses including pharmacy, offered in different countries is framed and approved by their respec�ve Regulatory Bodies. It is desired that coordina�ng Board at the global level be cons�tuted and assigned the task of the dra�ing common core syllabus for graduate program in pharmacy. This shall certainly facilitate free flow of knowledge seekers and knowledge disseminators across the globe which ul�mately, shall lead to universiliza�on and consolida�on of the profession.

Role Model in Science: Teacher, Advisor, Mentor and a Friend Srinivas Pentyala, Director of Transla�onal Research & Associate Professor, Department of Anesthesiology, Stony Brook Medical Center, Stony Brook, NY.

His educa�on includes MS (1986) Sri Venkateswara University Neurobiology Tirupa�, India, PhD (1989) Sri Venkateswara University Neurotoxicology Tirupa�, India and Post-Doctoral Fellow University of Mississippi Medical Signal Center, Jackson, MS Transduc�on.

His appointments includes From To Title Ins�tu�on & Loca�on 2006 Present Director of Transla�onal Research, Stony Brook Medical Center, Anesthesiology Stony Brook, NY, 2006 Present Clinical Associate Professor, Stony Brook Medical Center, Health Sciences Stony Brook, NY,2005 Present Adjunct Associate Professor, Dowling College, Biology Oakdale, NY, 2004 Present Adjunct Associate Professor, Adelphi University, Biology Garden City, NY and 2004 Present Adjunct Faculty, Urology, Stony Brook Medical Center and many more.

His Research interests includes 1.Rapid Diagnos�c methods2. G-proteins, PLC and Ca2+ signaling by Hormones, Anesthe�cs, Toxicants and Drugs. 3. Bioac�ve pep�des - Lead drug compounds discovery. 4. Matrix degrading Proteinases: Role and regula�on in cancer cells and Apoptosis.

Abstract:

Educa�on is cri�cal to the progress of humanity through its unveiling of the intricate processes that co-mingle in different aspects of life. Par�cularly, the next genera�on of ci�zens will carry a burden of scien�fic uncertain�es that will require the breaking of new fron�ers, discovery and inven�on for the very survival of humanity. Discrimina�on based on economic, social and racial status in the impar�ng of scien�fic knowledge, burdens society and slows the progression of scien�fic knowledge. Despite these challenges and the preeminence of the field of pharmacy research, students con�nue to lag behind, par�cularly in transla�ng scien�fic knowledge into applica�ons that are beneficial for mankind. The understanding of science beyond the textbook is not normally an aspect that is impressed upon young minds. This might be one of the strongest reasons why, students lose interest. Instead, they develop the no�ons that science is difficult and that the payoffs are intangible. Science is not just reading a textbook, following the syllabus and ge�ng high grades on an exam. Science is a process of measurement, observa�on, and reasoning that could answer society's most pressing ques�ons. If this idea is ins�lled into the students at an early stage, then sufficient talent may be a�racted to careers in the field of pharmaceu�cal sciences. On the other hand, if barriers are erected to talented individuals, the discoveries and progress will be insufficient to meet our needs. It is the responsibility of “a role model” to show that science is “COOL” as well as “HOT”, so that students can get involved in science that makes sense. Taking examples from a career spanning 25 years, the impact of commi�ed teaching, advising, mentoring, inspiring and exci�ng students will be discussed, highligh�ng several scien�fic inven�ons and discoveries in the process.

Entrus�ng Students to be Agents of ChangeRalph J. Al�ere, Professor and Dean of the University of Colorado Skaggs School of Pharmacy and Pharmaceu�cal Sciences, USA

Ralph J. Al�ere is Professor and Dean of the University of Colorado Skaggs School of Pharmacy and Pharmaceu�cal Sciences, USA. Professor Al�ere's career in educa�on and research spans nearly 35 years that includes several years in the pharmaceu�cal industry and over 30 years in faculty posi�ons at the University of Kentucky and the University of Colorado. Prior to taking on the role of associate dean for academic affairs, Dr. Al�ere

had a con�nuously funded research program for more than 15 years.

As associate dean for academic affairs at the University of Colorado Skaggs School of Pharmacy, he was responsible for leading the conversion of the pharmacy educa�on program from the BS to the Doctor of Pharmacy (PharmD) degree program and had administra�ve oversight for development of a largely online non-tradi�onal post-BS PharmD degree program. From 1998 to 2005, he was director of the Pharmacy Student Research Conference – Western Region. He served as a member of the advisory board for the UC Denver Center for Bioethics and Humani�es and the Colorado Clinical Transla�onal Sciences Ins�tute. He has held numerous posi�ons in the American Associa�on of Colleges of Pharmacy (AACP) including Chair of the Sec�on of Teachers of Biological Sciences and was a fellow in the inaugural AACP Leadership Fellows Program. He is the recipient, as co-author, of local and na�onal innova�ons in teaching awards, as well as the 2004 recipient of the University of Colorado Health Sciences Center Diversity Award and the University of Colorado Anschutz Medical Campus Chancellor's Diversity Recogni�on Award in 2007. As a leader in diversity efforts, Dr. Al�ere served as director of a HRSA Center of Excellence Diversity Program.

In his role as dean, he has administra�ve responsibility for a school na�onally ranked number 4 in research funding and in the top 20 percent of all pharmacy schools in the US, na�onally and interna�onally recognized clinical pharmacy programs and innova�ve interna�onal pharmacy educa�on programs. Professor Al�ere also serves as President of the Interna�onal Pharmaceu�cal Federa�on (FIP) Academic Pharmacy Sec�on and a member of the FIPEd Internal Reference Group, the FIP Board of Pharmacy Prac�ce, the FIP Congress Programme Commi�ee and the FIP Academic Ins�tu�onal Membership Advisory Group.

Abstract:

As pharmacy educa�on moves towards a more socially accountable and competency and performance based system, learning and assessment are expanding beyond the classroom and into the experien�al prac�ce based environment. The challenge and opportunity before us is how to prepare pharmacy students for a profession that is changing rapidly and that allows students to impact future direc�ons of the profession. In some countries, medical educa�on is mee�ng this challenge by adop�ng “Entrustable Professional Ac�vi�es” for students to perform. This workshop will begin by briefly describing the Entrustable Professional Ac�vity process as a mechanism to create acceptance of students' par�cipa�on in the health care process and sharing examples of student ac�vi�es in innova�ve experien�al se�ngs. The majority of �me will be spent with students exploring models of par�cipa�on in innova�ve prac�ce and strategies for overcoming challenges in this environment.

Learning outcomesPar�cipants will:1. Iden�fy the role of experien�al educa�on in various countries 2. Use the Entrustable Professional Ac�vi�es model to gain acceptance of student par�cipa�on in the health care process3. Determine challenges inherent in being a student in the health care environment and strategies for overcoming them.

Advanced learning and prac�ce - Crea�ng global standards

Dr. T. K. RaviPrincipal, College of Pharmacy,Sri Ramakrishna Ins�tute of Paramedical Sciences,Sri Ramakrishna Hospital Campus,Coimbatore. PIN: 641044

Dr. T. K. Ravi is the Principal and Head, Department of Pharmaceu�cal Analysis, College of Pharmacy, Sri Ramakrishna Ins�tute of Paramedical Sciences, Coimbatore with 27 years of experience. He obtained his Bachelor's, Master's and Ph.D. degrees in Pharmacy from College of Pharmaceu�cal Sciences, Manipal. In 27 years of his experience as a teacher and researcher he has to his credit, 41 interna�onal and 104 na�onal publica�ons in peer reviewed journals. He has successfully guided 50 postgraduate thesis, 11 doctoral thesis (Ph. D.) and presently guiding 6 doctoral research scholars in the field of Pharmaceu�cal Chemistry and Pharmaceu�cal Analysis. He served as a member in several na�onal and interna�onal professional bodies, which include Inspector and Member, Pharmacy Council of India, New Delhi. He is also a nominated Member, Council to Regulate Clinical Establishments in India, New Delhi. He has been elected three �mes as the Governing Council Member, President, Faculty of Pharmacy of The Tamil Nadu Dr. M.G.R. Medical University, Chennai. He is also one of the Board of Directors, Asian Associa�on of Schools of Pharmacy, Malaysia (2008-2015). He was also the Board of Studies and Research Board Member of many Indian Universi�esHe is a recipient of several pres�gious awards and fellowships which includes, “Dis�nguished Alumni award” of College of Pharmaceu�cal Sciences, Manipal, Karnataka; “Fellowship award of Associa�on of Biotechnology and Pharmacy” during 2009, IPA Fellow award and “Professional Excellence Award” by the Tamil Nadu Dr. M.G. R. Medical University. At present he is the Convener, Scien�fic Services Commi�ee, and Indian Pharmaceu�cal Congress Associa�on for a period of three years (2013-2015). He also served as the Treasurer, Indian Pharmaceu�cal Congress Associa�on, Chairman, and Scien�fic Services Commi�ee (LOC) for 64th IPC at Chennai during 2012 and was the Scien�fic Convener for the Indian Pharmaceu�cal Associa�on Conven�on 2009 & 2010. He was the Chairman of the II Na�onal Conven�on of Pharmacy Educators held at Coimbatore (2006) and was the Organizing Secretary, 4th Na�onal Conven�on of Associa�on of Pharmaceu�cal Teachers of India (1999). He is the life member of many professional bodies like IPA, IPGA, and APTI. He is a reviewer for various journals like Indian Journal of Pharmaceu�cal Sciences, Indian Journal of Pharmaceu�cal Educa�on, etc. He has also travelled widely and presented papers, delivered several invited lectures and chaired sessions in number of na�onal and interna�onal conferences.

Abstract:

Prac�ce of Pharmacy has a rich history of advancing prac�ce through innova�on. These innova�ons helped to mold Clinical prac�ce into a pa�ent-centered discipline recognized for its contribu�ons to improve medica�on therapy outcomes. The development of professional competency extends far beyond the mere acquisi�on of knowledge. Lecture-oriented classes generally result in students being passive learners, with informa�on memorized in the short term for an examina�on but forgo�en a�erwards. Lectures provide li�le opportunity for students to engage in thinking or problem-solving ac�vi�es, and are limited in their ability to elicit traits of professionalism. Ac�ve-learning strategies will improve reten�on of knowledge, thinking abili�es, problem-solving, and foster development of professional traits. Effec�ve performance of clinical ac�vi�es like medica�on history interview, clinical problem solving, medical informa�on evalua�on, drug therapy monitoring, pa�ent medica�on counseling, Drug Informa�on Services, ra�onal medica�on use, Adverse Drug Reac�on Management, Assessment of Drug Interac�ons etc., are the major skill sets defined for a professional Pharmacy prac�ce educa�on. Inquiry-based approaches may have par�cular value in health professions educa�on by allowing students to learn material in the process of applying it to solve actual pa�ent care problems. However, most prac�ce competencies are developed through a dynamic interplay between curricular components and prac�cal applica�on, and not solely developed in the experien�al learning environment. The growth of academic–prac�ce partnerships could improve this trend and s�mulate innova�on among the next genera�on of pioneering prac�cing professionals. Although collabora�on facilitates innova�on, academic ins�tu�ons and health care systems/organiza�ons are not taking full advantage of this opportunity. The academic–prac�ce partnership can be op�mized by making both partners accountable for the desired outcomes of their collabora�on, fostering symbio�c rela�onships that promote value added pharmacy prac�ce services and emphasizing con�nuous quality improvement in the delivery of these services. This further supports the idea that prac�ce experiences should occur con�nuously throughout the curriculum, not in discrete, isolated blocks. When evalua�ng and designing prac�ce models to achieve a preferred vision for pharmacy prac�ce, it is instruc�ve to examine the elements of pharmacy prac�ce that are essen�al to ensure op�mal medica�on use. In a fully integrated prac�ce model, pharmacists should have dedicated service assignments. The direct involvement of a pharmacist throughout the medica�on-use process has been shown to ensure con�nuity of care, reduce mortality rates, and minimize the risks, decrease the costs, and improve the outcomes associated with drug therapy. The academic–prac�ce partnership can foster innova�on by providing effec�ve leadership, adop�ng new approaches to professional educa�on and training. With appropriate leadership and support, a shi� in current professional educa�on, training prac�ces, and a commitment to cul�vate new and innovative practice advancements that will improve patient outcomes and maintain global standards in health care.

Empowering the Future Enterpreneur to global leadershipMr. Jayapal Reddy Thumma, Chairman of St.Peter's Group of Ins�tu�ons

Mr. Jayapal Reddy Thumma, a Master graduate in Business Administra�on and the Chairman of St.Peter's Group of Ins�tu�ons. Presently his Ins�tu�ons promote St.Peter's Pharmacy, Four Schools in SSC, CBSE and Interna�onal Schools apart from St.Peter's Engineering College. And also he is the Managing Director of Teach Global Services Pvt Ltd, Hyderabad.

Presently he is the Core Commi�ee Member of Indian Associa�on of Colleges of Pharmacy (IACP) in addi�on he is also the invitee member of the Execu�ve Council of Indian Pharmaceu�cal Associa�on( I P A), Mumbai. Presently Execu�ve Council Member of Indian Pharmaceu�cal Congress Associa�on ( I P C A). Took charge as President, General Secretary and Treasurer from 2001 to 2015 for Andhra Pradesh Pharmacy Colleges Associa�on which hasmore than 300 colleges in its fold.Mr Reddy also took ac�ve role in FIP World Congress 2011, Hyderabad in India Host Commi�ee. In 2012 as a Chairman LOC, St.Peter's Inst of Pharmaceu�cal Sciences, Warangal hosted IPA Student Congress which was the most successful events of IPA-SF and now Core Commi�ee Member of Students World Congress IPSF 2015. Apart from this organised Module I, II and VI of IACP Advanced Learning Series for Pharmacy Prac�ce & PharmD students. Also took ac�ve part in CEC of 1st Indian Congress of Pharmacy Prac�ce in 2014 at Bangalore by IACP. Apart from this organised more than 60 Na�onal Seminars/ Symposiums in Pharmacy & Engineering.Delivered several Lectures on Business Mgmt and Key-Note addresses on Na�onal pla�orms. Presented papers at FIP, AASP & other world congress meets and travelled to United States, Egypt, China, Swiss, Turkey, Portugal, Singapore, Indonesia, Dubai, Thailand, France, Uzbekistan, Nepal , Italy, etc .

Abstract:

This is an era of opportuni�es for the younger genera�on empowered with certain skill sets at the global level. As we are all aware that A�tude, Knowledge and Skills make an individual capable of working under any condi�ons of his profession, we shall now focus our discussion to health care profession in all aspects. When we refer to the buzzword “Global Leadership”, an aspiring entrepreneur such as a young pharmacy student has many aspects to look into. It all starts with what kind of persona he or she has. The power of thinking is so enormous that it develops a person's ability to control the en�re stream of business. It generates the long and un�ring strategy of adop�ng to understand economics from dreaming to delivering a product to the end user. The future global entrepreneur has to develop mul�dimensional thinking encompassing different business models, virtual R & D, marke�ng, various formats of supply chains and world taxa�on systems ahead. As we observe that the tradi�onal block buster models in terms of research, sales, dispensing and collabora�ons will disappear very soon. Already �me is witnessing a shi� from fixed dosage combina�ons to imaging, from imaging to �ssue engineering to therapeu�c monoclonals and nano pills to pharmacogenomics/biomarkers/gene-based therapies to nano carriers and very shortly to human cell therapies. We even will be shi�ing towards virtual process designs to valida�ons. There will be new manufacturing technologies such as flexible produc�on, con�nuous processing and automa�on to transgenic produc�ons. Even the health care market leadership of G7 na�ons will be coming down, as E7 na�ons will be growing at 300% against 40% of G7 na�ons. So, if a current pharma graduate chooses to empower himself with predic�ng the future trends of Global Pharma Markets, for sure he/she would be a front-runner to grab the Global leadership posi�on as an Entrepreneur.

QA of pharmacy educa�on. Role of stake holders.

Dr.T.V.Narayana completed his B.Pharm,M.Pharm, PhD from Andhra University, India and having 28 years of experience in Teaching and Administra�on at various capaci�es of Pharmacy Educa�on. Presently working as Director of Vikas Ins�tute of Pharmaceu�cal Sciences, Rajahmundry, AP. He is Mentor of the IPA Students Forum and with his guidance IPA SF achieved many honours and milestones including hos�ng of the 61st IPSF world congress

in India. He served as central council member of Pharmacy Council of India, New Delhi, a statutory body of Ministry of H&FW that regulates Pharmacy educa�on in India and ac�vely involved in various commi�ees of PCI like Professional Pharmacy commi�ee, Pharmacy Ethics and Educa�on Regula�ons Commi�ee and Na�onal Task Force for Quality Assurance of Pharmacy Educa�on. Dr.T.V.Narayana is also holding several posi�ons in various Pharmacy organiza�ons represen�ng Pharmacy Educa�on. He is Vice President of The Indian Pharmaceu�cal Associa�on, Mumbai and Chairman of IPA Educa�on Division for the fourth term, Hon Secretary of Pres�gious Indian Pharmaceu�cal Congress Associa�on (IPCA), Director of Indian Associa�on of colleges of Pharmacy, core commi�ee member of World Pharmacy Congress held at Hyderabad in 2011 and Joint Secretary of the 63rd IPC Bangalore 2012, LOC secretary of 17th APTI Conven�on in 2013, Hon Secretary of IPA Conven�on in 2014, etc. He has received several awards to his credit including the Fellowship of IPA in 2005 and Fellowship of Associa�on of Biotechnology and Pharmacy in 2007, Shikshak Bhushan award in the year 2008, BV Patel Trust Memorial Award in 1980 for securing 1st seat in Pharmacy. He has represented India in world Pharmacy congresses of FIP held at Bangkok in 2014, Amsterdam in 2012, Lisbon in 2010, Istanbul in 2009, and Beizing in 2008, as official representa�ve of IPA and par�cipated in Academic Pharmacy sec�on mee�ngs and Global Pharma Educa�on Task Force mee�ngs. He has presented 28 oral and 78 posters at both Na�onal and Interna�onal conferences of FIP, FAPA, AASP, held at Amsterdam, Portugal, Turkey, Australia. Switzerland, China, Philappines, Japan, Egypt, South Korea, Thailand etc., He is on editorial boards of reputed journals like Pharma Times, Pharmabit, Pharmanext, and advisory board member of 5 Pharmacy Ins�tutes.

He has organized 6 Interna�onal Conven�ons, 12 Na�onal workshops, 4 students' congresses, 95 seminars on career prospects in pharmacy at various places through out the country and par�cipated in more than 100 conferences as resource person. Abstract:

The origin of pharmacy ins�tu�ons in India dates back to 1899 in Madras for training of pharmacists followed by the state medical faculty of Bengal in 1928. The first UG program in pharmacy was started at BHU in the year 1932 with curriculum based on syllabus of University of London. Later various Universi�es in respec�ve states started the Pharmacy ins�tu�ons impar�ng Diploma, Undergraduate, Postgraduate and Doctoral programmes in Pharmacy. At present there are nearly 1100 ins�tu�ons offering various pharmacy programmes with an annual intake of nearly 60000 students. The Pharmacy Council of India (PCI) is a statutory body governed by the provisions of the Pharmacy Act 1948 passed by the Parliament regulates the Pharmacy educa�on and profession in India, The syllabus is more industry oriented rather than Prac�ce oriented and mainly focused to cater the needs of the Pharmaceu�cal Industry. The changing scenario in societal requirement and more emphasis on

health care system indicates a clear shi� in the science based pharmacy educa�on to prac�ce based recently in India. As a major breakthrough in the history of Pharmacy educa�on in India, the Pharm.D regula�ons have been no�fied in the Gaze�e of India on 10th May, 2008 with an aim to equip the future pharmacist of India with skills of not only dispensing medicines but also to serve as counselor of medicines with focus towards pa�ents and prescriber of drugs. At present nearly 150 ins�tu�ons are offering this programme throughout the country. As the programme is newly implemented, the PCI is organizing various training programs to the staff and students in associa�on with various stake holders to ensure that assured quality of pharmacy educa�on is maintained.

Subodh Priolkar is an MBA from NMIMS, Mumbai and B. Pharm. from Bombay College of Pharmacy, Mumbai. He has more than 30 years of experience in various mul�-na�onal pharmaceu�cal companies. He was responsible for spearheading business opera�ons of Aptar Pharma. He was elected in 2003 as the youngest ever President of IPA and was instrumental in various ac�vi�es in industry as well as in academia. He joined Colorcon in 2008 as Managing Director. As Regional managing director for Colorcon South Asia, he is responsible for the growth of business. His business acumen has led to the expansion and commissioning of the largest manufacturing facility of Colorcon in Goa, India.

Abstract:

In a 2004 report, Innova�on and Con�nuous Improvement in Pharmaceu�cal Manufacturing, US Food and Drug Administra�on, 2004, the US FDA put the problem this way: “Pharmaceu�cal manufacturing opera�ons are inefficient and costly. Compared to other industrial sectors, the rate of introduc�on of modern engineering process design principles, new measurement and control technologies, and knowledge management systems is low. Opportuni�es for improving efficiency and quality assurance . . . are not generally well recognized.”Addi�onally, pharmaceu�cal industry is under tremendous pressure as many countries are cu�ng their health care budget resul�ng in reduced prices and reimbursement rates. This evolu�on nega�vely affects gross profits and sales volumes. Increased compe��on takes place due to generic companies aggressively seeking to extend their market share. The R&D success rate of ethical pharmaceu�cal companies is substan�ally decreasing while patent protec�on of block busters of the '90's is slowly but surely fading away. All these factors lead to declining company revenues while increased R&D budgets are required to keep up R&D success rates of the past. This requires each en�ty of a company to dras�cally increase its efficiency. Product Development will need to find ways to speed up development and transfer. The Supply Chain en�ty as a result will need to reduce costs, improve produc�on economics and increase manufacturing flexibility. This presenta�on would highlight some of the advances in manufacturing of pharmaceu�cal dosage forms that could help develop robust formula�ons and increase the produc�vity.

Day 3 (August 2)

August 2 2015

9:00 - 9:45 Mr. Subodh Priolkar

9:45 - 10:30 Dr. Purnanand Sarma

10:50 - 11:35 Dr. Krishna Ella

11:35 - 12:20 Dr. Madhu Pudipeddi

13:40 - 14:25 Dr. Akash Mathur

14:25 - 15:10 Mr. Anirudh Gautam

15:30 - 16:15 Mr. Manni Kantipudi

16:15 - 17:00 Dr. Mahesh Bhalgat

Can India Sustain its Position as a Global Generics Provider

Innovation & Vaccine Hub of the World

Innovation and Entrepreneurship together Paving way for New Therapies with Better Outcomes

Day 3

Scientific Symposium "Catalyzing Innovation in Manufacturing and Delivery of Pharmaceutical Products"

Key-note address

Business Potential of Innovative Pharmaceutical Services vis a vis Pharmaceutical Products

Role of Innovation in Generic Product Development

Leveraging Innovation to offer Cutting Edge Pharmaceutical Research Solutions to Global Industry

Opportunities and Challenges in Biotechnology-based products and the Role India can Play

Innova�on and Entrepreneurship together Paving way for New Therapies with Be�er OutcomesDr. Purnanand Sarma (a.k.a. Sarma Duddu)

Dr. Purnanand Sarma (a.k.a. Sarma Duddu) serves as the President and Chief Execu�ve Officer at TARIS Biomedical in Lexington, MA, USA. Dr. Sarma has more than 23 years of execu�ve leadership experience in large Pharmaceu�cal and Biotech Companies, across 3 con�nents. Dr. Sarma has proven track record of building high energy teams and high value ventures. In his current role, he is aggressively building a high value specialty urology business at TARIS, based

on technology licensed from MIT and backed by leading US venture capitalists. In August 2014, he sold one of TARIS' highly specialized products (LiRIS®) for the treatment of Inters��al Cys��s to Allergan in a deal worth nearly $600M. Prior to TARIS, he held mul�ple execu�ve posi�ons, including General Manager and Vice President of Worldwide Drug Delivery Technologies at Cephalon Corpora�on, USA and Vice President of Worldwide Pharmaceu�cal Development and founding Managing Director of India Opera�on at Nektar Therapeu�cs, USA. Dr. Sarma started his career at SmithKline Beecham Pharmaceu�cals, in product development. Author of numerous peer-reviewed ar�cles, book chapters and patents, he is a frequent speaker at various technical and business forums. Dr. Sarma earned a Ph.D. in Pharmaceu�cs from the University of Minnesota and a B. Pharm. from Andhra University, Visakhapatnam, India.

Abstract:

Despite major investment in R&D, the innova�on gap in the Pharmaceu�cal industry con�nues. While quan�fiable clinical unmet need across mul�ple diseases is s�ll persists, unprecedented economic forces are re-defining the value of innova�on and cure. Rising reimbursement hurdle in the west is leading to the development of specialized products primarily for niche, high value indica�ons, such as cancer and hepa��s. Furthermore, this phenomena is promp�ng companies to focus only on those indica�ons/countries (e.g. US) where pricing and reimbursement is viable and jus�fies the cost of development. In this new economic reality, highly focused biotech/specialty Pharmaceu�cal companies are able to rapidly gain commercial advantage, leaving big pharmaceu�cal companies lagging behind. This dynamic presents problem (1) for large pharmaceu�cal company growth in terms of accessing and valuing innova�on (high demand, but limited supply), and (2) for developing countries, crea�ng a long-term gap in affordable new drugs aimed at diseases of the developing world, which affect broad pa�ent groups. At this juncture, it is clear that region-specific innova�on should be high on the list for various countries, in order to balance the health needs of world. In an interes�ng way, this phenomena provides opportuni�es for regional entrepreneurs to make a significant impact on global health.

Innova�on & Vaccine Hub of the WorldDr. Krishna M. Ella

Dr. Krishna M. Ella, the Chairman and Managing Director of Bharat Biotech Interna�onal Ltd, has graduated from the University of Agricultural Sciences-Bangalore, and the University of Hawaii and the University of Wisconsin- Madison. A�er comple�ng Ph. D from Madison, joined as faculty at the Medical University of South Carolina- Charleston. He moved to India

during 1997 to set up Bharat Biotech. Bharat Biotech has invested more than USD 150 million towards facili�es and projects, has sold more than 3 Billion doses in 65 countries. The company has created many new vaccines like Typhoid Conjugate Vaccine, Rotavirus. Under Social Innova�on concept, Bharat entered public-private partnership with DBT, Bill & Melinda Gates Founda�on, PATH, CDC-Atlanta, NIH-USA to develop ROTAVAC vaccine. Bharat Biotech was the first company in the developing world to conduct an Efficacy trial with a budget of USD 90 million. Recently ROTAVAC® the first novel vaccine which is completely developed in India was launched by our Hon'ble Prime MinisterBharat Biotech entered into a partnership with the University of Maryland to work on Non-Typhoid Salmonella (NTS) vaccines for Africa with a Grant of $ 4 Million from the Wellcome Trust. Bharat Biotech obtained more than 65 global patents with 8 new molecules. Both Bharat Biotech and Ella Founda�on together published more than 90 research ar�cles in peer review journals. The Ella Founda�on is a non for profit organiza�on purely focused on basic research in biological sciences with human and veterinary applica�ons. He was Advisor to CM of AP for crea�ng Knowledge Park which lead to Genome Valley which today created more than 10,000 jobs. Dr. Ella is ac�vely involved in shaping India's science educa�on and policy as well as Interna�onal collabora�on by being a Member, Advisor, and Chairman of numerous commi�ees. Prominent among them are: he is the member of Governing Body of the Council of Scien�fic and Industrial Research (CSIR); member of Scien�fic Advisory Commi�ee to the Cabinet (SAC-C); Chairman of Board of Governors of the Na�onal Ins�tute of Technology-Warangal. He served as Co-Chairman Indo-USA High Technology Coopera�on Group (HTCG) for 5 years on behalf of Govt. of India and facilitated Knowledge Ini�a�ve Bill signed by USA. He received Interna�onal guests like Hon President of USA -George Bush, Bill & Melinda Gates, the President of Gates Founda�on, Hon. President of South Africa and Myanmar, Senator Kerry, and many interna�onal visitors to Bharat Biotech. He received many awards such as Bio Spectrum Person of the year (2013); University of Wisconsin Dis�nguished Alumni Award (2011); Business Leader of the Year (2011); Silver Patent Award from Government of India (2011); Best Entrepreneur Award – BioSpectrum, the Rotary Interna�onal Fellowship; Best Technology and Innova�on Award from the Prime Minister of India (2008); Asia Pacific Biobusiness Leadership Award 2005 from University of Southern California; Dr. K.C. Cha�erjee – Memorial Award from Indian Pharmaceu�cal Associa�on, India (1999).

Abstract

Indian vaccine industry has emerged as the poten�al hub for vaccines for the world due to innova�on and innova�ve methods, sustained and uninterrupted supply of affordable, high quality vaccines to public vaccine markets globally. Innova�on resulted in the development of new vaccines for Japanese Encephali�s, Rotavirus from Indian strains, new conjuga�on methods for vaccines against Typhoid and Meningococcus by the vaccine manufacturers of India. Sustained and uninterrupted supply of affordable, high quality vaccines to UNICEF and to the private markets of other countries by India is over 56% of the annual global requirements of vaccines. India is poised to become the Innova�on and Vaccine Hub of the World due to its abundant skilled manpower and scien�sts, adop�on of leading edge technologies, ap�tude for innova�on in the development of new vaccines as the best public health interven�on for the preven�on and control of vaccine-preventable infec�ous diseases.

Can India Sustain its Posi�on as a Global Generics ProviderDr. Madhu Pudipeddi

Madhu Pudipeddi is a pharmaceu�cal professional with a proven track record of metrics-driven performance in the area of “chemistry, manufacturing, and controls (CMC)”. He has excellent professional reputa�on, global experience, cross-cultural awareness, strong people development skills, and outstanding scien�fic excellence. Madhu has nearly 20 years of experience in pharmaceu�cal development of new chemical en��es and technical

(manufacturing) opera�ons of generic drug products. Madhu is currently Regional Head – Europe & India, Manufacturing, Science and Technology (Solid Dosage Forms) in Sandoz AG, Switzerland. Previously, he had held posi�ons of increasing responsibility in Novar�s Pharmaceu�cals (USA & India) and Bristol-Myers Squibb (USA). He was awarded the pres�gious Novar�s Leading Scien�st Award (Viva Award) in 2010 for his contribu�ons in the area of Biopharmaceu�cs in Drug Development. Madhu was one of the recipients of Thomas Alva Edison Patent Award in 2014 from the R&D Council of New Jersey, USA. Madhu has published several papers in the area of physical pharmaceu�cs and formula�on development. Madhu holds a Ph.D. in Pharmaceu�cal Sciences from the University of Wisconsin, Madison, USA.He is Responsible for “MS&T – Solid Dosage Forms” func�on for Region Europe & India. He had a Key leadership role in business case evalua�on, site set-up, talent recruitment, reten�on, and development and opera�onal execu�on. Managed complex global projects from early through late phase technical development. Led a team of nearly 100 associates organized in a team based non-hierarchical structure to deliver on organiza�onal priori�es. He won pres�gious Novar�s VIVA Leading Scien�st Award in 2010

Abstract:

A brief history of the evolu�on of global generics business will be provided and the role of Indian Pharmaceu�cals will be elaborated. The current status of global pharmaceu�cal business will be reviewed, along with the contribu�ons of Indian Pharma to the global generics market. Historical factors that contributed to the current significance of Indian Pharma in global generics and their relevance to future developments will be analyzed. Recent trends in the generic market field and upcoming loss of exclusivity (LOE) opportuni�es will be examined. Examples of strategies by Generic companies for differen�a�on will be presented.

Business Poten�al of Innova�ve Pharmaceu�cal Services vis a vis Pharmaceu�cal ProductsAkash Mathur, Partner, Cardinal Points Consul�ng

Akash Mathur did his MBA, Marke�ng and corporate strategy, 1998 – 2000 in Washington University in St. Louis - Olin Business School; Ph D, Human Pathology, 1993 – 1998 in Saint Louis University; Master of Science (M.S.), Biophysics, 1988 – 1990 in All India Ins�tute of Medical Sciences

Abstract:

A brief history of the evolu�on of global generics business will be provided and the role of Indian Pharmaceu�cals will be elaborated. The current status of global pharmaceu�cal business will be reviewed, along with the contribu�ons of Indian Pharma to the global generics market. Historical factors that contributed to the current significance of Indian Pharma in global generics and their relevance to future developments will be analyzed. Recent trends in the generic market field and upcoming loss of exclusivity (LOE) opportuni�es will be examined. Examples of strategies by Generic companies for differen�a�on will be presented.

Role of Innova�on in Generic Product DevelopmentAnirudh Gautam

Did his B. Pharm, Ins�tute of Technology, Banaras Hindu University, Varanasi (India) in 1993 Later persued M. Pharm in Birla Ins�tute of Technology & Science, Pilani (India) in 1995 and finally completed his Diploma in Opera�onal Management (DOM) at Indra Gandhi Open

University in 1999.He was awarded the best poster award in 59th IPC, Varanasi for the category of Biopharmaceu�cs, Pharmacokine�cs and Drug Metabolism. He received a Cer�ficate of Apprecia�on in Ranbaxy for Team Excellence Award in 2006. He is the Topper of M. Pharm batch in 1995He has done almost 20 PUBLICATIONS & PRESENTATIONS �ll dateHe started his career as a Trainee Chemist-Produc�on in Bri�sh Health Products (I) Ltd., Dabur India Limited, Bhiwadi, Rajasthan. Later worked as Research Associate to Research Scien�st, Clinical Pharmacology & Pharmacokine�cs in Ranbaxy Research Laboratories. Then worked as Group Leader-Bioanaly�cs, Wellquest Clinical Research, Nicholas Piramal. He is currently working as a Senior Research Scien�st then Group Leader, Metabolism & Pharmacokine�cs, Ranbaxy Research Laboratories and promoted to Associate Director in the same Company.He has Nineteen years of experience in differen�ated formula�ons development, generics research, drug discovery and development in therapeu�c areas like neurology, dermatology, malarial, inflammatory diseases, arteriosclerosis and BPH He also has In-depth exposure in designing Bio studies for evalua�ons of IR and NDDS formula�ons, providing inputs as PK expert to product development teams and also has Rich experience of outsourcing preclinical and clinical ac�vi�es to Indian and Interna�onal CROs; nego�a�ng �me and money as well as developing them as strategic partners.

Abstract:

Innova�on is the hallmark of science. The life sciences and pharmaceu�cal science in par�cular are no different. In colloquially sense generic product development may seem to be agnos�c to innova�on and has been looked down upon by innovator pharmaceu�cal giants as science of copying and reverse engineering. Though the big and small generic players in the industry have been trying to proclaim their product development as exclusive and painstaking research work, they could seldom get it to the status of innova�on. With the evolu�on of newer and advance technologies in product development and their use, both for and against the barriers to generic entry, has led to the recogni�on of novelty and originality in generic product development.

The dread of patent cliff and the eluding breakthrough innova�on in new drug discovery space has persuaded the Big Pharma to embrace generic product development as life cycle management of their own products. This phenomena has enthused greater play of innova�on in generics business. The role of innova�on in generic product development encompasses product per say to some extent, the process to a very large extent and supply management in the newest term. The abundance of dosage forms, routes and delivery systems of medicine for the treatment of whole array of disease condi�ons provides ample prospects to revolu�onise designing of generic pharmaceu�cals of proven quality. Its great sa�sfac�on as a pharmaceu�cal scien�st to see that the ul�mate beneficiary of the usage of excellent scien�fic advances are the pa�ents at large who get an access to affordable medicine.

Leveraging innova�on to offer cu�ng edge Pharmaceu�cal Research Solu�ons to Global IndustryManni Kan�pudi

Manni Kan�pudi is the Chief Execu�ve Officer of GVK Biosciences and Inogent Laboratories. Prior to becoming the CEO, Manni was the President of GVK Biosciences from 2007 to 2010. Before joining GVK Biosciences, Manni spent 16 years with Intel Corpora�on in various leadership posi�ons in the US and Asia. Manni was responsible for se�ng up Intel's engineering presence in India and headed up Intel India from 2000-2003. Manni was the CIO (Chief Informa�on Officer) of Intel for Greater Asia from 2003-2004 and supported all Intel IT requirements for over 25,000 employees in Asia. Manni was Director of So�ware for Intel's Wi-Fi Centrino product line from 2004-2007 where he brought to market successful products in high volume.

Opportuni�es and Challenges in Biotechnology based products, and the Role India can playDr. Mahesh Bhalgat

Dr. Mahesh Bhalgat has over 25 years of experience in the field of biotechnology and biologics. Following the comple�on of his B.Pharm from the University of Mumbai, Mahesh went to USA for advanced studies and obtained his Ph.D. in Medicinal Chemistry from the University of Utah. During his 20 year stay in the USA, his breadth of experience grew through working in many different func�ons within the

biotechnology industry. He has hands on experience working in the areas of Analy�cal and Process Development, Opera�ons, Regulatory Sciences and Quality.

During the span of his career in the US, Dr. Bhalgat has worked in both small and large companies such as Amgen, Monsanto, Celera Genomics and Molecular Probes (now Invitrogen). A�er returning to India, Mahesh started working in Biological E and is now Execu�ve Director and Chief Opera�ng Officer at Shantha Biotech. At Shantha, Mahesh is heading manufacturing, supply chain, quality and projects for the two facili�es located in Hyderabad. Mahesh has experienced the diverse applica�ons of biotechnology by working in biotherapeu�cs, vaccines, agri-biotech, research reagents and more.

During his illustrious career, Mahesh has contributed to the commercializa�on of diagnos�c kits, biopharmaceu�cals including monoclonal an�bodies and the WHO pre-qualifica�on of vaccines.

Abstract:

The modern-world biotechnology has grown substan�ally and found applica�ons in many complex processes such as manufacturing of vaccines that can effec�vely help in control of complex medical condi�ons, to the development of biotechnologically cured seeds that substan�ally improve yields of crops across the world.The Indian biotech industry is among one of highest growth industries with significant opportuni�es ahead. The presence of biotechnology solu�ons in India has placed India amongst the top 12 biotech des�na�ons in the world and also ranks third in the Asia-Pacific region.Due to the mul�-disciplinary nature of the solu�ons applicable, biotechnology industry provides an opportunity for scien�sts from many diverse backgrounds technologists to engage in driving progress in the use of biotechnology products and solu�ons.

August 3 2015 Day 4Excursion

Ras- Halls- Topaz, Diamond, Emerald, Turquoise, Coral

Day 4 (August 3)

Excursion: You will be taken on a tour to explore the city of Hyderabad.

Places you will seeŸ CharminarŸ Mecca MasjidŸ Chowmahala PalaceŸ Golconda fort

You can explore the rest of the city on your own during the free night. Dress Code: All the Par�cipants must wear their congress T-shirts along with their IDs

Day 5 (August 4)August 4 2015

9:00 - 10:30IPSF Clinical Skills Event -

Introductory WorkshopSaree Draping-Exclusively

for GirlsAttitude to Altitude in Pharmacy

Profession Increasing the

Employability Quotient

11:00 - 12:30IPSF Patient Counseling Event -

Introductory WorkshopTurban Draping- Preferably

for BoysAttitude to Altitude in Pharmacy

Prrofession Effective Documentation

13:30 - 15:00IPSF Compounding Event -

Introductory WorkshopEPSA-IPSF Workshop

Continous Manufacturing, “Granulation”: An overview

Student Exchange Officer- Workshop

15:30 - 17:00Pharmacy at Your Fingertips –

Using Technology to Strengthen Your Therapy Decisions

IPSF 7 Minutes to Inspire AMR: Clinical Skills &

Awareness"Pharmaceutical R&D: New

frontiers of innovation"

Day 5

GA

IPSF CLINICAL SKILLS EVENT - INTRODUCTORY WORKSHOPVenue: Topaz HallSpeaker: Mr. Nathan Ting, IPSF CSE CoordinatorThis workshop will define clinical skills focus on what it means to prac�ce in a clinical se�ng. In this workshop and in the compe��on par�cipants will have the opportunity to learn a systema�c approach to iden�fying and solving drug-related problems for their pa�ents. The workshop will cover some basic tools that can be applied in your future prac�ce as a pharmacist which can later be applied in the CSE compe��ons. These basic skills will help provide a founda�on for the par�cipants who are interested in par�cipa�ng in the individual or the team compe��on subsequent to the workshop.

SAREE DRAPING-EXCLUSIVELY FOR GIRLSVenue: Amber HallWorkshop by RCLearn how to look like a Desi girl

ATTITUDE TO ALTITUDE IN PHARMACY PROFESSIONVenue: Coral HallSpeaker: Dr. Mahesh Burande, President, Associa�on of Pharmaceu�cal Teachers of IndiaEverybody want to become successful in life. To become successful Knowledge,skill,hard work and most important posi�ve a�tude is required to bring every dream in to reality.

While achieving success there are many hurdles,problems,failures and even resistance from your surroundings. Once you develop posi�ve a�tude you take this obstacles as stepping stones in achieving your mission. This presenta�on will illustrate many case studies in pharmacy profession who achieve highest peak in pharmacy profession in achieving the des�na�on. A�tude to Al�tude will inspire everybody to decide the big dream in pharmacy profession and road to reach to Everest in your own field.

INCREASING THE EMPLOYABILITY QUOTIENTVenue: Turquoise HallSpeaker: Dr. Pradeep Desai, Advisory in- Management, Engineering and Commercializa�on of Products, Solu�ons, Services One of the thing that lingers in most peoples mind is how to get a good job. In a highly compe��ve global world, ge�ng gainfully employed and be successful is a challenge. Increasing the Employability Quo�ent (EmQ) is important as it increases the chances of ge�ng a job in alignment with the individual's interest. Employability Quo�ent (EmQ) as i define, is a measure of preparedness towards ge�ng employed. In this workshop we will discuss the various cons�tuents of EmQ and how to increase the EmQ. We will also discuss the interview process and how to prepare for an interview. Effec�vely managing the interview process is an integral part of increasing the EmQ. Increasing the EmQ has larger posi�ve impact for the community and the economy.

IPSF PATIENT COUNSELLING EVENT - INTRODUCTORY WORKSHOPVenue: Topaz HallSpeaker: Ms. Stephanie MillerThis workshop will review the process of pa�ent counselling and what it means to prac�ce this in a clinical se�ng. In this workshop and in the compe��on par�cipants will have the opportunity to prac�ce these skills by counselling a pa�ent actor. All pharmacists should use a systema�c approach when counselling pa�ents to ensure the medica�on dispensed will be safe and effec�ve for the pa�ents. This approach shall be taught in the workshop and then prac�ced in the event itself.

TURBAN DRAPING- PREFERABLY FOR BOYSVenue: Amber HallWorkshop by RC'Son of Sardar' or Pride of pagdi. Learn turban draping the desi-style

EFFECTIVE DOCUMENTATIONVenue: Turquoise HallSpeaker: Dr. Kaushik Desai, Hon.Secretary General, Indian Pharmaceu�cal Associa�on

The Pharmaceu�cal industry operates in a mul�billion pounds / euros / dollars global market place. Its opera�ons

are highly complex and so are its regula�ons. Proper understanding of documenta�on principles is the crux to

GMP in the pharmaceu�cal industry. There is no stage in the life cycle of drugs that does not undergo regula�ons

and documenta�on irrespec�ve of whether it is the laboratory phase of a new molecular en�ty discovery, tes�ng

in clinical trials, or the licensing, manufacturing, and distribu�on. It is impera�ve to maintain a standard

documenta�on system for compliance to regulatory system. Good Documenta�on Prac�ces (GDP) assist in

preven�ng errors with various processes related to quality of drugs and the manufacturing facili�es. There has

been increasing regulatory oversight as compared to the past and many warning le�ers are issued by Regulatory

authori�es worldwide based on improper records and documenta�on.

IPSF COMPOUNDING EVENT - INTRODUCTORY WORKSHOPVenue: Topaz HallSpeaker: Mr. Renato Nolasco, IPSF CE CoordinatorThe workshop will be an interac�ve presenta�on focussing on the art and prac�ce of compounding pharmaceu�cal formula�ons. The presenta�on will go over this history of compounding, what is important when compounding a pharmaceu�cal product and a future perspec�ve. Furthermore the par�cipants of the workshop will be prepared for the compe��on, where they can challenge their theore�cal knowledge from pharmaceu�cal technology and prac�cal knowledge in compounding.

IPSF-EPSA WORKSHOPVenue: Amber HallSpeaker: Mr. Jose Carvalho/ Katarzyna Świderek, EPSA PresidentThe Oxford dic�onary defines 'Advocacy' as the 'public support for, or recommenda�on of a par�cular cause or policy'. Advocacy can take different forms and serve different purposes. In this workshop we will introduce tools used in advocacy and then we will work together on the areas of interest of pharmacy students, at local, na�onal or in the case of EPSA (European Pharmaceu�cal Students' Associa�on) - European level.

EPSA is a non-profit, non-poli�cal organisa�on, represen�ng 160 000 pharmacy students from 35 countries across Europe. The Associa�on exists to develop the interests and opinions of European Pharmacy Students and to encourage contact and coopera�on between them. To understand advocacy on European level, we will go through European Union ins�tu�ons and their role in developing laws that concern every member in their everyday lives. Based on EPSA's example, we will discuss the differences between various levels of advocacy (local, na�onal and European), but also how all layers can support each other and work towards the same goal.The workshop is targeted for par�cipants eager to get to know and put into prac�ce the approaches used when advoca�ng for their interests, as well as the interests of their Associa�ons on various levels.

CONTINUOUS MANUFACTURING, “GRANULATION”: AN OVERVIEWVenue: Emrald HallSpeaker: Mr. Devashish Bakshi, Managing Director ,Tapasya Engineering works Pvt. LtdThe vision of con�nuous manufacturing is of an industry with processes that are integrated, based on a systems approach, having model-based control, and making use of flow. Thus, seeing as a con�nuous manufacturing process. The brief enlightenment of various approaches for con�nuous manufacturing such as Hot Melt Extrusion, Roll Compac�on, Top Spray Granula�on with merits and demerits.

STUDENT EXCHANGE OFFICER- WORKSHOPVenue: Coral HallSpeaker: IPSF Execu�ve Commi�ee

PHARMACY AT YOUR FINGERTIPS – USING TECHNOLOGY TO STRENGTHEN YOUR THERAPY DECISIONSVenue: Turquoise HallSpeaker: Eric Tan, Regional Sales Manager, Wolters Kluwer Clinical Drug Informa�on

IPSF 7 MINUTES TO INSPIREVenue: Topaz HallThis session was developed based on the idea of IPSF Talk that was ini�ated at the 59th IPSF World Congress in Utrecht, the Netherlands. "IPSF 7 Minutes to Inspire” will consist of interac�ve sessions where par�cipants are invited to give a 7-minute presenta�on, speech, or even show to inspire the audiences to adopt new innova�ve ideas or join a cause they passionately support. If you love TED talks, you will love this session.A panel of judges will be appointed to provide feedback to the par�cipants' performance, and at the end of the session, the audiences will get the chance to vote on the Most Inspiring Par�cipant. For par�cipants, it is a great opportunity not only to share your ideas but also to develop your presenta�on skills.

AMR: CLINICAL SKILLS & AWARENESSVenue: Amber HallSpeaker: Ms. Lara Turiya Seitz, IPSF Medicine Awareness Coordinator

"PHARMACEUTICAL R&D: NEW FRONTIERS OF INNOVATION"Venue: Coral HallSpeaker: Dr. Satya Lakshmi Orugan�, Scien�fic Manager Drug Repurposing Programme GVK BiosciencePharma companies are con�nuously being challenged by shrinking pipelines and rising costs of drug development which leads to the absolute necessity for innova�on. Hence, for the pharma industry, it is a compulsion offering survival advantage. Innova�on has been the mantra for most of the pharma companies in the form of novel target discovery, drug discovery, safer routes of administra�on etc. However, recent �mes have seen tremendous transforma�on in nature and structure of the novel prac�ces to meet pa�ent, regulatory, healthcare and other stakeholder demands. Scope for transforma�on in the pharma industry lies in two direc�ons: one in the scien�fic and technology aspects of crea�ng treatments and the other in crea�ng superior business models crea�ng a win-win situa�on for all the stakeholders such as investors, pa�ents and the pharma company. 'Open Innova�on' and 'Crowd sourcing' are two ideas that big pharma is embracing deeply for gaining a compe��ve advantage over nimble start -ups. Big pharma as defined by giants such as Pfizer, Merck and Johnson and Johnson is marked by a growth pa�ern which is o�en inorganic, through mergers and acquisi�ons. However, with the number of start-ups increasing consistently, the importance of size in innova�on is being understood. The agility and flexibility of start-up environment is proven to foster innova�on be�er thus leading to a change in landscape. What exactly do we mean by the word 'innova�on'? It is more o�en a slow, incremental process that cannot be automated and mostly involves changing mindsets. It can be applied equally well to products, processes and organiza�ons although the methods may vary dras�cally. Hence, transforming thought processes is the norm of the day and the only choice available for gaining compe��ve edge.

NEON PARTYVenue: Marrio� Conven�on CentreDress Code: Lab coats, neon accessories.Things you will need: Markers, Fluorescent paint.

Day 6 (August 5)

BREAKFASTVenue: Pearl Garden

INDUSTRIAL VISITGrab the chance to visit the pharmaceu�cal industries in India. A�endance is compulsory for all delegates (except the official delegates). Delegates will be divided into 5 groups and will get chance to share their views of different industries. The industries will be either of the following: (1) Lab India Analy�cal Instruments (2) Sipra Labs (3) Natco Pharma Ltd. (4) Vimta Labs Ltd. (5) USP

PHC PREPARATIONSVenue: Halls – Turquoise, Topaz, Opal, Amber, Coral HallsLots of ac�vity in store for Public Health Campaign on next day

DINNERVenue: Shilparamam

INDIAN NIGHTVenue: ShilparamamDesi, Desi, Desi….All the way Desi!

August 5 20159:00 - 10:3011:00 - 12:3013:30 - 15:0015:30 - 17:00

Industrial visit

PHC PreparationsGA

Day 6

Day 7 (August 6)August 6 2015

9:00 - 10:30Public Health:

Communicating in the Digital Age

Project Management -

11:00 - 12:30 IPSF Clinical Skills Event -

Case Presentation Competition

Present needs of the Indian Pharma Industry from

Academia -

13:30 - 15:00

The 3rd IPSF Young Researchers’ Forum I - World Café Discussion on Pharmacy

Students Involvement in Research Projects

RC Workshop - Reserved

15:30 - 17:00

The Great New Challenges facing the Pharmacists Worldwide in the New

Millennium

-

IPSF Clinical Skills Event - Team Competition

IPSF Patient Counselling Event - Beginner Preliminaries

IPSF Patient Counselling Event - Advanced

Preliminaries

PHC Group 1

PHC Group 2

Day 7

IPSF CLINICAL SKILLS EVENT - TEAM COMPETITIONVenue: Diamond HallSpeaker: Mr. Nathan Ting, IPSF CSE CoordinatorThis workshop will define clinical skills focus on what it means to prac�ce in a clinical se�ng. In this workshop and in the compe��on par�cipants will have the opportunity to learn a systema�c approach to iden�fying and solving drug-related problems for their pa�ents. The workshop will cover some basic tools that can be applied in your future prac�ce as a pharmacist which can later be applied in the CSE compe��ons. These basic skills will help provide a founda�on for the par�cipants who are interested in par�cipa�ng in the individual or the team compe��on subsequent to the workshop.

PUBLIC HEALTH: COMMUNICATING IN THE DIGITAL AGEVenue: Emrald HallSpeaker: Mrs. Nirma Khatri Vadlamudi. Quality Specialist, Parexel."According to an Ins�tute of Medicine (2004) report, low health literacy nega�vely affects the treatment outcome and safety of care delivery. Several studies reveal that up to half of pa�ents cannot understand basic healthcare informa�on. The mismatch between a clinician's level of communica�on and a pa�ent's ability to understand can lead to medica�on errors and adverse medical outcomes. The lack of health literacy affects all segments of the popula�on, although it is dispropor�onate in certain demographic groups, such as the elderly, ethnic minori�es, recent immigrants and persons with low general literacy. Pharmacist plays a key role in bridging the gap of lack of health literacy skills among pa�ents and improper communica�on with clinicians through health communica�on.In this Public Health Communica�on workshop, the instructor takes the par�cipants through various behavior change theories, health message framing strategies, communica�on styles to effec�vely develop public health message for Direct Pa�ent Care, Counseling or Public Health campaigns. Par�cipants will get hands-on experience by working on real case studies".

PROJECT MANAGEMENTVenue: Coral HallSpeaker: Mr. Murthy Chi�oory, Vice-President, Venky Parenterals

IPSF CLINICAL SKILLS EVENT - CASE PRESENTATION COMPETITIONVenue: Emrald HallSpeaker: Mr. Nathan Ting, IPSF CSE Coordinator

PRESENT NEEDS OF THE INDIAN PHARMA INDUSTRY FROM ACADEMIAVenue: Coral HallSpeaker: Dr. B. Prabha Shankar

IPSF PATIENT COUNSELLING EVENT - BEGINNER PRELIMINARIESVenue: Diamond HallSpeaker: IPSF Execu�ve Commi�ee Member

IPSF PATIENT COUNSELLING EVENT - ADVANCED PRELIMINARIESVenue: Emerald HallSpeaker: IPSF Execu�ve Commi�ee Member

THE 3RD IPSF YOUNG RESEARCHERS' FORUM I - WORLD CAFÉ DISCUSSION ON PHARMACY STUDENTS INVOLVEMENT IN RESEARCH PROJECTSVenue: Amber Hall

THE GREAT NEW CHALLENGES FACING THE PHARMACISTS WORLDWIDE IN THE NEW MILLENNIUMVenue: Coral HallSpeaker: Lt.Col. Prasad Tirunagaru, Lieutenant Colonel US Army.Lt. Colonel Prasad received his B.Pharm & M.Pharm degrees from Andhra University and Medical Service Core training as a combat pharmacist at the Academy of Health Sciences of US Army Medical department centre, Texas, USA. The was the first South Indian to be commissioned as an officer in the US Army. He was the first foreigner to pass the pres�gious California State Board Exams in the world. He has thirty five years of experience as a registered pharmacist in USA, as Assistant Chief and Chief of Pharmacy in various army medical centres. Special�es include clinical research in developing human gene�c insulin, nutri�onal studies, in-pa�ent and outpa�ent pharmacies, oncology, chemotherapy and nuclear pharmacies.

Developed hospital formulary, clinical training modules for healthcare professionals.

The whole world is facing increasing economic impact of increased prices of medica�on. Uncle Sam in USA, the

Lords of London and the aging popula�on in the whole world need help ge�ng affordable quality medica�on.

Day 8 (August 7)August 7 2015

9:00 - 10:30 Gattefosse

The National Health Service in the UK: The

Cost of Care and Future of Hospital Pharmacy

TRIPS and Post 2015: Opportunities to improve access

to medicine

Conflict Resolution in Workplace relationships

11:00 - 12:30Role of IPC in defining and

maintaining quality standards of Medicines

Root Cause Analysis and CAPA system

Improving Patient Compliance by Formulation Design

Packaging Validation: A critical need to ensure valid

product

13:30 - 15:00IPSF Clinical Skills Event -

Individual AdvancedModel UNESCO

IPSF Clinical Skills Event - Individual Beginners

Pharmacovigilence: An eye for detail in ADR

Management

15:30 - 17:00Pharmacy Education Summit:

Being the Ambassador for Change!

Model WHO IPSF Training OpportunitiesQuality Risk Management

in Pharma Industry

GA

Compounding event (from

13:00)

Day 8

GATTEFOSSE VENUE:Coral hall.

THE NATIONAL HEALTH SERVICE IN THE UK: THE COST OF CARE AND FUTURE OF HOSPITAL PHARMACYVENUE: Topaz hall.ABSTRACT: The UK prides itself on having one of the best healthcare systems in the world; the NHS (Na�onal Health Service). In recent years there has been increasing stress on the NHS with li�le investment from the government causing increased wai�ng �mes in A&E, understaffed and crowded hospital wards. Pharmacists are in a key posi�on to develop their role to meet the sustained demand for a high quality health service under budget restraints. Hospital pharmacy is now exploring different avenues to s�ll provide high quality care whilst not increasing costs of the service. A discussion on posi�ves of hospital pharmacy in respec�ve countries around the world will help built ideas for the future.

TRIPS AND POST 2015: OPPORTUNITIES TO IMPROVE ACCESS TO MEDICINEVENUE: Opal hall.:CONFLICT RESOLUTION IN WORKPLACE RELATIONSHIPSVENUE: Amber hall.NAME OF THE SPEAKER::Dr. Samson Gandhi.ABSTRACT: A life that is not examined is not worth living. - SocratesHuman rela�onships are the essence of life - at home or at work. Harmony in rela�onships is the joy of life. We all desire and strive to maintain peaceful rela�onships. However reality speaks a different line. Conflicts are part of our everyday work-life. We cannot wish them away. They are inevitable. Those that know how to resolve conflicts will enjoy work, and, therefore become more produc�ve contribu�ng to the bo�om line of the company.Resolving conflicts is easier said than done. People are unique with different temperaments, come from contras�ng cultures and operate in variety of situa�ons. All these factors contribute to a complex work culture prone to conflicts. However, we learn to survive by adop�ng different conflict resolu�on strategies. These are picked up early in our life and modify them as we go along.

At this seminar, you will be able to understand why we have conflicts in workplace rela�onships. Then discover your own conflict resolu�on style through a ques�onnaire/instrument given to you. At this seminar, you will be able to understand why we have conflicts in workplace rela�onships. Then discover your own conflict resolu�on style through a ques�onnaire/instrument given to you. Later, through a process of discussion you will be able to appreciate different conflict resolu�on styles, understand why you choose a par�cular conflict resolu�on style and find out if there is one best conflict resolu�on style.Come for a fun-way of learning.

ROLE OF IPC IN DEFINING AND MAINTAINING QUALITY STANDARDS OF MEDICINES:VENUE: Emerald hall.NAME OF THE SPEAKER: Dr. Purandh sahu.ABSTRACT: Effec�ve and safe use of drug can only be ascertained by the quality of drug. A goal; which every manufacturer try to achieve, maintain and every regulator try to ensure. This goal can be achieved only first by defining and guarding the path. That par�cular path is shown & being guarded by Indian Pharmacopoeia Commission by defining various standards and parameters. These standards and parameters transcribed into a book of standards, 'Indian Pharmacopoeia'. For assuring quality of drugs, IP is published with regular updates, reflec�ng the updates and changes in the technology and regula�ons.IP conceptualize various parameters and test standards according to regional need. Another tool for ascertaining quality of drugs very finely is the Indian Pharmacopoeia Reference Standard (IPRS). In order to assure and verify the quality of medicines manufactured and marketed in India would require IPRS which act as a fingerprint for iden�fica�on, strength and purity of medicines. IPRS not only has the poten�al to define as well as maintain the test standards which are very vulnerable to the varia�ons that may arise at the hands of analyst, and various physical, chemical & even geographical condi�ons, at a level where these can't be affected by the varia�ons. ISO standards are being followed at Indian Pharmacopoeial Laboratory to provide bedrock to the scien�fic literature published in IP and for assuring quality of IPRS.Safety of drugs ensured by quality but must be watched carefully at individual level keeping in mind individual varia�on. Pharmacovigilance Programme of India being a part of IPC since 2011 has taken this endeavour. Na�onal Formulary of India a book that describe proper and safe use of drugs to maximise benefit and minimise side effects of drugs

NAME OF THE SESSION: Root Cause Analysis and CAPA system VENUE: Amber hall. NAME OF THE SPEAKER: Mr. Narendira KumarABSTRACT: Iden�fying the root cause for market complaints, out of specifica�ons (OOS), devia�ons can be challenging, but a number of tools can help to inves�gate the root cause so that correc�ve and preven�ve ac�ons can be effec�vely implemented. FDA's Quality System Regula�on as well as the new guidelines on “Quality Systems Approach to Pharmaceu�cal Current Good Manufacturing Prac�ce Regula�ons” requires effec�ve correc�ve and preven�ve ac�ons (CAPA) with root cause analysis (RCA) as reac�ve tool for system improvement to ensure that significant problems do not re-occur.The CAPA system is the most frequently inspected subsystem. No or inadequate procedures for correc�ve and preven�ve ac�ons (CAPA) and missing root cause analyses are amongst the most frequently found devia�ons in FDA warning le�ers. Having compliant procedures for CAPA and compliant management is a must for any firm in the Medical Device manufacturer, Pharma Industry, regardless of marketplace. Successfully implemen�ng and documen�ng correc�ve and preven�ve ac�ons (CAPA) is one of the cri�cal processes in a medical device and pharmaceu�cal manufacturing company's day-to-day quality opera�ons.

CAPAs carry significant implica�ons for both product quality and compliance with FDA regulatory direc�ves, and remain vital to any company's ability to address incidents that inevitably arise in the manufacturing processes. Due to this, it is cri�cal to take necessary steps to prevent them from re-occurring.Root cause analysis is a completely separate process to incident management and immediate correc�ve ac�on, although they are o�en completed in close proximity.The individual(s) tasked with ascertaining the underlying root cause must look beyond the obvious and make a serious a�empt to pinpoint root cause. The good news is that there are tools available for inves�gators to facilitate their quest for ascertaining root cause.Most regulatory bodies have similar requirements for CAPA and complaint management.

NAME OF THE SESSION: Improving Pa�ent Compliance by Formula�on DesignVENUE:Diamond hall.NAME OF THE SPEAKER:Mr. Shantanu DamleABSTRACT: With evolving regula�ons, the Pharmaceu�cal Industry now needs to focus on Pa�ent compliance as one of the most important Aspects while marke�ng their product. There are new guidance documents from Regulators like US FDA indica�ng Pa�ent safety and Compliance being one of the important objec�ve of companies launching any medica�on. Though, it is a more of a company level ac�vity and strategy, the onus ul�mately comes on to the formula�on Scien�st to ensure that he/she makes the formula�on not only in compliance to the regula�ons, compendia, but also keep an eye on how to improve its compliance to the pa�ents. This paradigm shi� would change the way we approach our formula�on development ac�vi�es and puts more focus on Safety by Design as part of development. The presenta�on will cover various aspects on how pa�ent compliance can be improved by use of simple techniques like Coa�ng, Impact of size and shape of the dosage form to improve swallowability, taste masking of bi�er tas�ng drugs, limi�ng the size of ER dosage forms etc. The ul�mate aim of all these aspects would be to help reduce medica�on errors, Ease of iden�fica�on, swallowability and palatability of dosage forms in – turn helping to improve the pa�ent compliance. The presenta�on will also talk of different Brand enhancement tools that help companies differen�ate their dosage form in the crowded market and helps their product stand out from compe��on.

NAME OF THE SESSION: Packaging Validation: A critical need to ensure valid productVENUE: Opal hall.NAME OF THE SPEAKER: Mr. Surender ManekABSTRACT: In the Pharmaceu�cal industry, GMPs are essen�al to ensure that consistent quality products are manufactured and delivered to the pa�ents. Valida�on is now a Key requirement of all GMP Guidelines, as a validated process enables consistent manufacturing and packaging of products in accordance with the product quality and market requirements in a cost effec�ve and secure manner. Various Valida�on ac�vi�es required for a Pharmaceu�cal products are captured in a Master Valida�on Plan for the facility. It is observed that the Packaging Valida�on perse is generally not specified as a separate valida�on ac�vity but considered as part of a Product Process Valida�on ac�vity and some aspects of it are covered during Process Valida�on. Packaging valida�on: It should form part of an overall Valida�on program in the plant, to confirm that the resul�ng product from a specified packaging process consistently conforms to product a�ributes and the customer requirements. It is a risk-based approach, primarily focussing on the packaging processes that have the greatest poten�al risk to product quality and thereby provides a ra�onal framework for developing an appropriate scope for packaging valida�on ac�vi�es. The Workshop will cover and highlight the need and the importance of Packaging valida�on, its impact on the Quality of the products and key ac�vi�es to achieve it successfully.the greatest poten�al risk to product quality and thereby provides a ra�onal framework for developing an appropriate scope for packaging valida�on ac�vi�es.The Workshop will cover and highlight the need and the importance of Packaging valida�on, its impact on the Quality of the products and key ac�vi�es to achieve it successfully.

NAME OF THE SESSION: IPSF CLINICAL SKILLS EVENT - INDIVIDUAL ADVANCEDVENUE: Diamond hall.ABSTRACT: This workshop will define clinical skills focus on what it means to prac�ce in a clinical se�ng. In this workshop and in the compe��on par�cipants will have the opportunity to learn a systema�c approach to iden�fying and solving drug-related problems for their pa�ents. The workshop will cover some basic tools that can be applied in your future prac�ce as a pharmacist which can later be applied in the CSE compe��ons. These basic skills will help provide a founda�on for the par�cipants who are interested in par�cipa�ng in the individual or the team compe��on subsequent to the workshop.

NAME OF THE SESSION: IPSF CLINICAL SKILLS EVENT - INDIVIDUAL BEGINNERSVENUE: Emerald hall.ABSTRACT: This workshop will define clinical skills focus on what it means to prac�ce in a clinical se�ng. In this workshop and in the compe��on par�cipants will have the opportunity to learn a systema�c approach to iden�fying and solving drug-related problems for their pa�ents. The workshop will cover some basic tools that can be applied in your future prac�ce as a pharmacist which can later be applied in the CSE compe��ons. These basic skills will help provide a founda�on for the par�cipants who are interested in par�cipa�ng in the individual or the team compe��on subsequent to the workshop.

NAME OF THE SESSION: AN EYE FOR DETAIL IN ADR MANAGEMENT VENUE: Amber hall.NAME OF THE SPEAKER: Dr. Ramesh AdepuABSTRACT: Medicines are being used to treat various illnesses as they have the ability to modify the altered physiological processes in the body. But at the same �me, due to various predisposing factors such as age, gender, co morbidi�es, poly pharmacy and gene�c pre disposi�on,o�en medicines pose certain amount of risk in the form of unwanted effects that are known as adverse drug reac�ons (ADRs) and causes morbidity and mortality. The burden of ADRs is first known to the world through Thalidomide disaster in 1960's. Many research studies further have corroborated the high incidence and severity of the problem posing risk to general wellbeing and increased health care expenditure. New drug molecules are being introduced in to the market based on efficacy and safety evidences. However during the post marke�ng, o�en pa�ents experience adverse events due to various predisposing factors. Pharmacovigilance (PV) is a scien�fic studythat detects, assesses, understands and preventsthe adverse effects or any other drug-related problem. Spontaneous repor�ng system is an easy, convenient and economical method o�en used by health care professionals to report ADRs. Many countries encourage pharmacists to report ADRs. The Uppsala monitoring center (UMC) is the opera�onal arm of the WHO Interna�onal Drug Monitoring program.UMC collects global ADR data, especially from WHO interna�onal drug monitoring program member countries.In India, Pharmacovigilance Program of India (PvPI) generates an independent data on the safety of medicines. Health care professionals use PvPI ADR repor�ng forms to collect the informa�on on adverse drug reac�ons from pa�ents. Completely and accurately filled ADR no�fica�on forms may be sent to local ADR Monitoring centers (AMC) for further evalua�on and processing.

NAME OF THE SESSION: PHARMACY EDUCATION SUMMIT: BEING THE AMBASSADOR FOR CHANGE!VENUE: Diamond hall.

NAME OF THE SESSION: MODEL WHO VENUE: Emerald hall.ABSTRACT:In this session there will be a simula�on of the World Health Assembly. Each delegate will represent a country and some background research on the topic provided will be necessary. Delegates will follow the rules of WHA such as speaking order, �me given to speak, among others.

NAME OF THE SESSION:IPSF TRAINING OPPORTUNITIESVENUE: Topaz hall.ABSTRACT:A�er the introduc�on of TRIPS, the world of healthcare has hit heavily as developing countries were ge�ng limited access to healthcare. In order to improve the public health stature of the developing countries, paragraph 6 of the Doha Conven�on of WTO, popularly known as 'Doha Declara�on' has given the developing countries a golden opportunity to manufacture their own medicine in addi�on to expor�ng to other developing countries without TRIPS �ll a period of 2015. This par�cular declara�on has effected greatly on some of the developing countries, developing medicines of excellent quality to improve the public health stature of the locality as well as expor�ng to the developed countries by mee�ng their quality standard entering stringent drug market. The interes�ng query can come to the mind, as 2015 is drawing near end, how the developing countries will be able to cope with it and the subsequent changes that would take place in the world of healthcare.

NAME OF THE SESSION:QUALITY RISK MANAGEMENT IN PHARMA INDUSTRYVENUE: Amber hall.NAME OF THE SPEAKER: Mr. Narendira KumarABSTRACT: Risk management principles are effec�vely u�lized in many areas of business and government including finance, insurance, occupa�onal safety, public health, pharmacovigilance, and by agencies regula�ng these industries. Although there are some examples of the use of quality risk management in the pharmaceu�cal industry today, they are limited and do not represent the full contribu�ons that risk management has to offer. In addi�on, the importance of quality systems has been recognized in the pharmaceu�cal industry and it is becoming evident that quality risk management is a valuable component of an effec�ve quality system. It is commonly understood that risk is defined as the combina�on of the probability of occurrence of harm and the severity of that harm. However, achieving a shared understanding of the applica�on of risk management among diverse stakeholders is difficult because each stakeholder might perceive different poten�al harms, place a different probability on each harm occurring and a�ribute different severi�es to each harm. In rela�on to pharmaceu�cals, although there are a variety of stakeholders, including pa�ents and medical prac��oners as well as government and industry, the protec�on of the pa�ent by managing the risk to quality should be considered of prime importance. The manufacturing and use of a drug (medicinal) product, including its components, necessarily entail some degree of risk. The risk to its quality is just one component of the overall risk. It is important to understand that product quality should be maintained throughout the product lifecycle such that the a�ributes that are important to the quality of the drug (medicinal) product remain consistent with those used in the clinical studies. An effec�ve quality risk management approach can further ensure the high quality of the drug (medicinal) product to the pa�ent by providing a proac�ve means to iden�fy and control poten�al quality issues during development and manufacturing. Addi�onally, use of quality risk management can improve the decision making if a quality problem arises. Effec�ve quality risk management can facilitate be�er and more informed decisions, can provide regulators with greater assurance of a company's ability to deal with poten�al risks and can beneficially affect the extent and level of direct regulatory oversight. .

August 8 2015

9:00 - 10:30Good practices in

pharmaceutical industryPharmacokinetics and its

applicationsIPSF Patient Counselling Event -

FinalsHow to Run an Innovative

Public Health

11:00 - 12:30Engaging Pharmacy Students in

Public Health Activities

Career opportunities in Regulatory Affairs utilizing knowledge of Regulatory

Sciences

IPSF Clinical Skills Event- Jeopardy

How to Run an Innovative Public Health

13:30 - 15:00Mrs. Archana Mugdhal workshop

- Waiting for confirmationChallenges of Membership

Promotion

Herbal formulation industry in India: Challenges and

opportunities

GMP - Recent Trends and developments

15:30 - 17:00Pharma Research: Industry-

Academia-Regulatory Concern, case Studies

Research Methodologies Pediatric Pharmacy Strategies for writing

research paper

Day 9

GA

Day 9 (August 8)

GOOD PRATICIES IN PHARMACEUTICAL INDUSTRY.VENUE: Coral hallSPEAKER: Dr.Abdul bari.ABSTRACT: Good prac�ces like GMP and GLP are necessary condi�ons for marke�ng authoriza�on of pharmaceu�cal products globally. A number of countries require manufacturers of industrial chemicals, pharmaceu�cals, veterinary drugs, pes�cides, cosme�c products, food products, feed addi�ves, etc., to establish through data that use of these products do not pose any hazards to human health and the environment. Good prac�ces require major investments in upgrading manufacturing facili�es to comply with interna�onal rules and standards. Good prac�ces in produc�on and quality control, provides guidance on ac�ons to be taken separately by produc�on and by quality control personnel for the implementa�on of the general principles of QA .Good prac�ces needs to be established through studies and data, which will be examined by the regulatory authori�es of the concerned countries. Good Laboratory Prac�ce (GLP) is a system, which has been evolved by Organisa�on for Economic Co-opera�on and Development (OECD) used for achieving the above goals. Indian small pharma industries should be aware of the good prac�ces to reach globally.

PHARMACOKINETICS AND ITS APPLICATIONSVENUE: Amber hall.SPEAKER: Prof. K. P. R. ChowdharyABSTRACT: Pharmacokine�cs is the study of kine�cs of absorp�on, distribu�on, metabolism and elimina�on (ADME) of drugs in the body. The disposi�on of the drug in the body is mathema�cally described by various kine�c models. The knowledge of pharmacokine�c is useful in es�ma�ng dosage and dosage schedules; in the design of controlled drug delivery systems; in iden�fying drug -drug interac�ons; in dosage adjustments; in therapeu�c drug monitoring and for comparing drug products. The principles of pharmacokine�cs, compartment models pharmacokine�cs parameters, their assessment and applica�ons and case studies illustra�ng the applica�ons of pharmacokine�cs are discussed in this presenta�on.

IPSF PATIENT COUNSELLING EVENT - FINALSVENUE: Diamond hall.SPEAKER: Stephanie MillerABSTRACT: This workshop will review the process of pa�ent counselling and what it means to prac�ce this in a clinical se�ng. In this workshop and in the compe��on par�cipants will have the opportunity to prac�ce these skills by counselling a pa�ent actor. All pharmacists should use a systema�c approach when counselling pa�ents to ensure the medica�on dispensed will be safe and effec�ve for the pa�ents. This approach shall be taught in the workshop and then prac�ced in the event itself.

HOW TO RUN AN INNOVATIVE PUBLIC HEALTHVENUE: Emerald hall.SPEAKER: IPSF Execu�ve Commi�ee

ENGAGING PHARMACY EDUCATION IN PUBLIC HEALTH ACTIVITIES.VENUE: Amber hall SPEAKER: Mrs. Manjiri GharatABSTRACT: Public health ini�a�ves emphasize the preven�on of diseases. It recognize the health needs of the popula�on as a whole and availability of the quality health and disease preven�on services. Worldwide, Community pharmacies provide a range of public health services with promising improvements in health access and outcomes. The budding pharmacists also can play important role in public health improvement right from their student phase. Public oriented ac�vi�es not only gives them an insight in the real health issues of the society but also overall enhances the interest in pharmacy educa�on and its applica�ons for the society. The presenta�on discusses the posi�ve and inspiring experiences of engaging pharmacy students in Tuberculosis Control ac�vi�es, Medicine Literacy campaigns and few other community service ac�vi�es.

CAREER OPPORTUNITIES IN REGULATORY AFFAIRS UTILIZING KNOWLEDGE OF REGULATORY SCIENCESVENUE:Topaz Hall.SPEAKER: Dr. Subhash C. MandalABSTRACT: A Pharmacy Graduate or Post Graduate in pharmacy may opt for different specializa�ons like-Research, Manufacturing, Quality Control, Quality Assurance, Marke�ng etc. Generally they get exposure in the selected field only. A manufacturing Pharmacist generally gets opportunity to manufacture a single category, if not so fortunate to get exposure to all types of manufacturing. Similarly a QC Pharmacist gets hardly any exposure in other areas like -manufacturing, sales etc. But a Pharmacist op�ng for Regulatory Affairs requires handling of Manufacturing, Quality Control, Product Development, Clinical Trial, and Quality Assurance of medicines. He needs to handle not only Allopathic medicines, but also other systems like -Ayurvedic including Siddha, Unani and Homoeopathy also. A regulatory Pharmacist requires to be an expert on Blood Banks, Medical Devices, Cosme�cs etc. as these are integral part of func�oning under FDA. Being a regulatory personnel, a pharmacist needs to handle Import and export ma�ers and thus must be an expert in this ma�er –requiring to be conversant with the regulatory mechanisms like-ICH, USFDA, EDQM, MCA, TGA, WHO cer�fica�on etc. Regulatory personnel not only deal with Drugs and Cosme�cs Acts, but also deal with other related laws like- IPR, Paten�ng, Copy Rights and Trade Marks, DPCO etc.. This is very important in case of introduc�on of a new product and even introduc�on of Generics in other countries. Therefore, RA covers a vast area in the pharmaceu�cal profession, providing immense opportunity of work. Addi�onally, there is tremendous scope for Regulatory personnel in Pharma Industry throughout the Globe.

IPSF CLINICAL SKILLS EVENT- JEOPARDYVENUE: Diamond hall.Abstract: This workshop will define clinical skills focus on what it means to prac�ce in a clinical se�ng. In this workshop and in the compe��on par�cipants will have the opportunity to learn a systema�c approach to iden�fying and solving drug-related problems for their pa�ents. The workshop will cover some basic tools that can be applied in your future prac�ce as a pharmacist which can later be applied in the CSE compe��ons. These basic skills will help provide a founda�on for the par�cipants who are interested in par�cipa�ng in the individual or the team compe��on subsequent to the workshop.

“ SKILL DEVELOPMENT WORKSHOP - BRIDGING THE GAP BETWEEN ACADEMY AND PHARMA INDUSTRY" VENUE: Amber HallSPEAKER: Dr . M.Venkata Reddy, Director, Hitech Inst. of Adv. Pharmaceu�cal SciencesGlobally pharmacy profession and educa�on are undergoing unprecedented change as the role of the pharmacist as a provider of healthcare services is increasingly recognized, valued, and expanded. Many countries are however, faced with cri�cal shortages of skilled pharmacy workforce. In this world of specializa�on and globaliza�on, the pharmacy educa�on in India is suffering from serious backdrops and flaws.

The main reason for the setback is due to the curriculum followed by most of the universi�es which is not up to the mark, but the poten�al for growth of pharmacy profession is enormous if we upgrade our standards of educa�on to the global expecta�ons. The gap between academy and pharma industry has to be properly bridged by providing systema�c industry oriented prac�cal training. This skill development programmes will enhance the knowledge of budding pharmacists for be�er opportuni�es.Further similar to the quality assurance which Pharma industries give for the drugs they manufacture as a statutory requirement, Pharmacy ins�tu�ons shall also give assurance for the quality of educa�on they provide.

CHALLENGES OF MEMBERSHIP PROMOTIONVENUE: Topaz hall.Abstract: Promo�ng the Federa�on to non-members countries and universi�es is the only way to achieve the worldwide representa�on of the Pharmacy Students. Nevertheless, promo�ng and adding new members to IPSF is heavily influenced by Social, Economic, Poli�cal, Ideological and Historical ques�ons of the country. Therefore, an analysis of those subjects are essen�al for developing the IPSF representa�on not only in PARO, but also in the whole world.

HERBAL FORMULATION INDUSTRY IN INDIA: CHALLENGES AND OPPORTUNITIESVENUE: Diamond hallNAME OF THE SPEAKER:Mr.Abdul bari.Abstract: India also known as the medicinal garden of the world as rich source of medicinal plants available in India. India with ancient civiliza�on is s�ll u�lizing herbs for curing diseases for safety and cultural acceptability in the name of Ayurveda,Siddha,Unani and yoga. Tradi�onal Medicine will contribute to human health care in the 21st century. The new genera�ons and researchers should take care of this ancient knowledge of herbs to produce excellent delivery systems. There is an urgent need for Indian research to focus on the areas of quality, documenta�on, standardiza�on and clinical evidence. Evalua�on of tradi�onal medicines on scien�fic ground is challenging and thrust area. We should focus on measures to be adopted for global promo�on of Indian herbal products in terms of Nutraceu�cls, Cosmeceu�cals, and Dietary supplements and also Bulk herbal extracts. The herbal companies should comply with global standers (WHO GMP) for manufacturing of herbal drugs under GLP and GMP condi�ons. Herbal industries, research ins�tutes, Indian pharmacopeia commission and AYUSH departments should work together to develop new technologies for promo�ng exports. Time has to come to accept the same synthe�c drug regula�ons for herbal remedies. The golden dictum for herbal medicines is “Effec�ve Regula�ons Improve Research”

GMP - RECENT TRENDS AND DEVELOPMENTSVENUE: Emerald hall.SPEAKER: Mr. Amaresh Tumbagi, Deputy Drug Controlller, Karnataka State

PHARMA RESEARCH: INDUSTRY-ACADEMIA-REGULATORY CONCERN, CASE STUDIESVenue: Amber hall.SPEAKER: Dr. P.G. Shrotriya, Director, Pharma Research, SPTM-NMIMS Pharma Research is in the Centre of a having Industry - Academiaand Regulatory Compliance in the three angle with Govt. Policy and Pharmacy Students in the arms.It covers Influence of Govt. Policy on Development of Pharma Research and Industry Interna�onally. Role of Academia cannot be undermined as a Bank of Human Resource.

The main reason for the setback is due to the curriculum followed by most of the universi�es which is not up to the mark, but the poten�al for growth of pharmacy profession is enormous if we upgrade our standards of educa�on to the global expecta�ons. The gap between academy and pharma industry has to be properly bridged by providing systema�c industry oriented prac�cal training. This skill development programmes will enhance the knowledge of budding pharmacists for be�er opportuni�es.Further similar to the quality assurance which Pharma industries give for the drugs they manufacture as a statutory requirement, Pharmacy ins�tu�ons shall also give assurance for the quality of educa�on they provide.

CHALLENGES OF MEMBERSHIP PROMOTIONVENUE: Topaz hall.Abstract: Promo�ng the Federa�on to non-members countries and universi�es is the only way to achieve the worldwide representa�on of the Pharmacy Students. Nevertheless, promo�ng and adding new members to IPSF is heavily influenced by Social, Economic, Poli�cal, Ideological and Historical ques�ons of the country. Therefore, an analysis of those subjects are essen�al for developing the IPSF representa�on not only in PARO, but also in the whole world.

HERBAL FORMULATION INDUSTRY IN INDIA: CHALLENGES AND OPPORTUNITIESVENUE: Diamond hallNAME OF THE SPEAKER:Mr.Abdul bari.Abstract: India also known as the medicinal garden of the world as rich source of medicinal plants available in India. India with ancient civiliza�on is s�ll u�lizing herbs for curing diseases for safety and cultural acceptability in the name of Ayurveda,Siddha,Unani and yoga. Tradi�onal Medicine will contribute to human health care in the 21st century. The new genera�ons and researchers should take care of this ancient knowledge of herbs to produce excellent delivery systems. There is an urgent need for Indian research to focus on the areas of quality, documenta�on, standardiza�on and clinical evidence. Evalua�on of tradi�onal medicines on scien�fic ground is challenging and thrust area. We should focus on measures to be adopted for global promo�on of Indian herbal products in terms of Nutraceu�cls, Cosmeceu�cals, and Dietary supplements and also Bulk herbal extracts. The herbal companies should comply with global standers (WHO GMP) for manufacturing of herbal drugs under GLP and GMP condi�ons. Herbal industries, research ins�tutes, Indian pharmacopeia commission and AYUSH departments should work together to develop new technologies for promo�ng exports. Time has to come to accept the same synthe�c drug regula�ons for herbal remedies. The golden dictum for herbal medicines is “Effec�ve Regula�ons Improve Research”

GMP - RECENT TRENDS AND DEVELOPMENTSVENUE: Emerald hall.SPEAKER: Mr. Amaresh Tumbagi, Deputy Drug Controlller, Karnataka State

PHARMA RESEARCH: INDUSTRY-ACADEMIA-REGULATORY CONCERN, CASE STUDIESVenue: Amber hall.SPEAKER: Dr. P.G. Shrotriya, Director, Pharma Research, SPTM-NMIMS Pharma Research is in the Centre of a having Industry - Academiaand Regulatory Compliance in the three angle with Govt. Policy and Pharmacy Students in the arms.It covers Influence of Govt. Policy on Development of Pharma Research and Industry Interna�onally. Role of Academia cannot be undermined as a Bank of Human Resource.

Our SupportersWe would like to thank all our Sponsors for their support. Without them our this event would not have been possible.

Industry Associate: Technical Sponsor:

Silver Sponsor:

Gattefosse India Ltd.

Symposia Partner Scientific Partner

Event Sponsor

R. L. Fine Chem

IndianPharmaceuticalAssociation

Tamil Nadu IPA Trust

Teach Global Solutions Pvt. Ltd.

Reverb IT Solutions

IndianPharmaceuticalAssociation

IPA Bengal Pharmaand Healthcare Trust

Media Partner

IPA Pharmatimes

IndianPharmaceuticalAssociation

The Indian Pharmacist

Supporting Media Partner

Cito Healthcare Pvt Ltd is a pharmaceutical and healthcare industry services company with four vertical objectives

· Product Sourcing covering bulk actives, intermediates, pharmaceutical formulations, neutraceuticals etc

· Project Sourcing including clinical trials encompassing pre-clinicals, proof of concepts, CEPs, bioequivalence, early stages like phase-I and late stages

· Academic collaborations for student exchange, faculty exchange, twinning of programmes

· Training encompassing GxP and placement founded by Mr.Sankara V Krishna Prasad in 2010, the company has made its mark in various areas some of which are the following:

· Won Healthcare Delivery Excellence Award for Marketing & Business Development from Indus Foundation, New Jersey at the Indo Global Healthcare Summit & Expo 2014, presented by the Hon'ble Healthcare Minister, Telangana on 22nd June 2014.· Organizing Committee Member – Indus Foundation Healthcare and Education Summits & Expos

· Organizing Committee Member – Omics Group Internationals Conferences & Expos - Pharma Industry Co-ordinator - Industrail Development Forum · Associate of Pan IIT organization for their industry interphase especially in pharma sector. Tied up with an associate for the Annual Conference of IIT 2014 for Scientific Content Partnership· Efforts are on to bring alliance among Pharmexcil and AAPS, GPhA of USA Brought together the Indus Foundation and Pharmexcil Brought together the Omics and Indus Foundation. Brought an alliance between competing CROs to complement (based on clinical and analytical strengths in the BA/BE space)· Coordinator –Drugs & Pharmaceuticals-IDF. Instrumental in getting Pharmexcil and IDF together to liase with the Govt of Andhra Pradesh and ensured allocation of 10 acres of land for P h a r m e x c i l a n d allied offices at Visakhapatnam.

th· Co-chair, Press and Publicity, 66 IPC, Hyderabad. Instrumental in getting the Telangana Government associate with the event and participate· Panel speaker at CII, AP's meet on Logistics in the state of Andhra Pradesh in the presence of J a p a n e s e delegation at Vijayawada.· Conference Chairman, CII, Institute of Logistics, “Healthcare Supply Chain” coordinating with t h e knowledge partner Tata Strategic Management Group to plan the conference, for the proposed one in 2015 at HICC. Minster for Health, Telangana is being brought as the chief guest apart from an array of speakers spanning manufacturing, courier organisations, regulators, researchers and other service providers.. Industry Associate, 61st IPSF World Congress 2015, Hyderabad

For more information, please refer to www.citohealthcare.com

With Best ComplimentsFrom

With Best ComplimentsFrom

Gattefosse India Ltd.

With Best ComplimentsFrom

With Best Compliments From

A.M. Reddy Memorial College Of Pharmacy

With Best Compliments From

(APTI)

With Best Compliments From

With Best Compliments From

With Best Compliments From

Creative Education Society’sCollege of Pharmacy

“If you don’t build your dream,

someone

else

will

hire you to help them

build theirs.”

Wishthegreatsuccess

for

“61st

IPSFWorldCongress”

IndianPharmaceuticalAssociation

M.P.StateBranch,Indore

104,ShrinathNiketan,29,SnehlataGanj,Indore

(M.P.)

With Best Compliments From

K.C REDDY INSTITUTE OF

PHARMACEUTICAL SCIENCES Jangamguntlapalem (P), Medikonduru (M),Guntur-522438, A.P

Ph: 08641-239498, 9441215475.

Email: kcr_bpharmacy@yahoo.com, Website: www.kcr.ac.in

Approved By AICTE & PCI- New Delhi

Affiliated to Acharya Nagarjuna University, Guntur

Courses Offered:

§ B.PHARMACY

§ M.PHARMACY

ü Pharmaceutics

ü Pharmaceutical Analysis &

Quality Assurance

ü Pharmacology Dr.D.SRINIVASA RAO

M.Pharm., Ph.D

Principal & Professor

With Best Compliments From

With Best Compliments From

MAM College Of Pharmacy

With Best Complimentsfrom

Shreyaas Health Care

With Best Compliments From

S�������� Instituteof Pharmaceutical Sciences

With Best Compliments From

With Best Compliments From

With Best Compliments From

Talla Padmavati College of Pharmacy

With Best Compliments From

Vignan Pharmacy College

With Best Compliments From

Special Thanks ForSupporting Public Health Campaign

&

Zilla parishad High School, Kukatpally

Auxilium High School, Mahindra Hills

Special Thanks ForSupporting Industrial Visit

¢ United States Pharmacopoeia¢ Lab India Analytical Instruments¢ Sipra Labs Ltd.¢ NATCO Pharma Ltd.¢ Vimta Labs Ltd.

With Best Compliments From

Contact Person:Mr. Srinivas (Marketing Manager)Contact Number:+91-22-28643481Address:10/D, 2nd Floor, Matru Ashish Building, Near Balbharti School, S V Road, Kandivali (W), Mumbai,Maharashtra, India.

Certainant Infrastructures PVT LTD

Certainant is an infrastructure development company providing end to end real

estate solutions. We bring in our innovation, experience and expertise together to

create optimal living spaces of enduring value to our clients. Certainant builds

deserving homes with ful l spectrum of lifestyle you rightfully deserve.

Mr Ajay - +919740899250 Office address - No.205 1st Floor, JSA Towers, Double Road Indiranagar 2nd Stage, Bangalore-560038 Tel : +918067651000

Mobile 8884439184/8884439187 Email : sales@certainant.coma Web - www.certainant.com

Durgadevi MotorsOwner: Nandkumar K Panickar Phone : +91 9820141689A d d r e s s : E l p h i n s t o n e R o a d . M u m b a i - 2 5

Manufacturers of Truck and Bus radials, Car tyres, etc.

With Best Compliments From

Factory Address:

J-174, M.I.D.C.,Tarapur, Boisar, Thane - 401 506TeleFax : +91 02525 270561 / 272129

Office Address:

A/101, Prathna Apartment, Plot No. 15, Jawahar Nagar, S.V.Road, Goregaon (West) Mumbai - 400 062 INDIA

TeleFax : +91 22 28725367 / 28738643 / 28773023Email: info@samrudhpharma.com

Cito Healthcare 64

TSIIC 65

Ga�efosse 66

Dr. Reddy’s 67

Mylan 68

Omics Interna�onal 69

54th IPC Trust 70

A.M. Reddy Memorial College Of Pharmacy 71

Associa�on of Pharmaceu�cal Teachers of india 72

Shree Chaitanya Ins�tute of pharmaceu�cal sciences 73

Chebrolu hanumaiah ins�tute of pharmaceu�cal sciences 74

Chitkara University 75

Crea�ve Educa�on Society’s college of pharmacy 76

Ins�tute of Pharmaceu�cal Educa�on and Research 77

Indian Pharmaceu�cal Associa�on M.P. State Branch, Indore 78

K.C. Reddy Ins�tute of Pharmaceu�cal sciences 79

KRL Pharmacy College 80

MAM College of Pharmacy 81

Narasaraopeta ins�tute of pharmaceu�cal sciences 82

Pra�shta Ins�tute of Pharmaceu�cal sciences 83

Pulipa� Prasad College of Pharmaceu�cal Sciences 84

Shreyaas Healthcare 85

Siddhartha College of Pharmaceu�cal Sciences 86

Sri Indu Group of Educa�onal Ins�tu�ons 87

Sri Padmavathi School of Pharmacy 88

Srinivasa Ins�tute of Pharmaceu�cal Sciences 89

Surabhi Educa�onal Society 90

St. Peter’s Ins�tute of Pharmaceu�cal Sciences 91

Suven Life sciences 92

Sri Venkateshwara C.K. College of Pharmacy 93

Talla Padmava� College of Pharmacy 94

Vignan Pharmacy College 95

Vikas College Pharmaceu�cal Sciences 96

Vikas College Pharmaceu�cal Sciences 97

Lupin 98

Florance old age home & medical services 100

(IPMAT) Ins�tute of Pharmaceu�cal Training 100

Devson Impex Pvt. Ltd. 100

Praga� House of Pharma machineries 101

Synpure Labs India Pvt. Ltd. 102

JPN Pharma Pvt. Ltd. 102

Certainant Infrastructures Pvt. Ltd. 103

Durgadevi Motors 103

Samrudh Pharmaceu�cals 104

Name Pg. No.